The SHAPE of tRNA folding and of the 5'-end of the HIV-1 genome by Wilkinson, Kevin A.
  
 
 
 
The SHAPE of tRNA folding and of the 5'-end of the HIV-1 genome 
 
 
Kevin A. Wilkinson 
 
 
A dissertation submitted to the faculty of the University of North Carolina at Chapel Hill 
in partial fulfillment of the requirements for the degree of Doctor of Philosophy in the 
Department of Chemistry. 
 
 
Chapel Hill 
 
 
2007 
       Approved By 
       Kevin M. Weeks 
       Linda L.  Spremulli 
       Howard M. Fried 
       Matthew Redinbo 
       Ronald Swanstrom 
 
 
 ii 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
© 2007 
Kevin A. Wilkinson 
ALL RIGHTS RESERVED
 iii 
 
 
 
 
 
 
 
Abstract 
 
 
Kevin A. Wilkinson 
 
 
The SHAPE of tRNA folding and of the 5'-end of the HIV-1 genome 
(Under the direction of Kevin M. Weeks)  
 
 Most RNAs function only once they fold to form difficult-to-predict base-paired 
helices and other structural elements. As an RNA forms a preferred secondary or tertiary 
structure, a characteristic set of nucleotides becomes constrained by base pairing and 
higher-order interactions, while unconconstrained positions remain flexible. Determining 
local nucleotide flexibility as a function of nucleotide position in a folded RNA provides 
important information that enables the sequence and structure of an RNA to be related to 
its biological function. 
 I have developed a technology, termed selective 2'-hydroxyl acylation analyzed 
by primer extension (SHAPE), that can be used to interrogate RNA structure under 
diverse in vitro and in vivo conditions. SHAPE chemistry can be applied to monitor 
protein binding events and locate promising sites for primer annealing in arbitrary RNA. 
SHAPE chemistry is based on the discovery that flexible RNA nucleotides preferentially 
sample conformations that enhance the nucleophilic reactivity of the 2'-hydroxyl group 
toward electrophiles, such as N-methylisatoic anhydride. Modified sites are detected as 
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stops in an optimized DNA primer extension reaction, followed by sizing of the extension 
products. SHAPE chemistry scores local flexibility at all four ribonucleotides in a single 
experiment and discriminates between base-paired versus unconstrained residues with a 
dynamic range of 20-fold or greater. 
I have applied SHAPE chemistry to observe equilibrium melting of a model 
tRNA at single nucleotide resolution. I observed that RNA folding is a complex process 
involving structural rearrangement and the formation of tertiary structure concurrent with 
secondary structure.  
Furthermore, I have employed capillary electrophoresis and sophisticated analysis 
algorithms to create a high-throughput SHAPE (hSHAPE) experiment that can 
comprehensively interrogate the flexibility of several hundred nucleotides in a single 
robust experiment.  
Using hSHAPE, I analyzed the structure of HIV-1 genomic RNA as a function of 
4 different biologically relevant states, including infectious viral particles. Despite many 
thermodynamically plausible structures, the HIV-1 genome exists in a single 
conformation. I observed the effects of tRNA primer binding, and the effects of 
nucleocapsid protein on RNA flexibility. hSHAPE chemistry is a promising, scalable 
approach that can rapidly and accurately analyze the structure of RNA molecules under 
biologically relevant conditions.  
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CHAPTER 1 
 
RNA AND FOLDING 
 
 
1.1 RNA structure 
Ribonucleic acid (RNA) plays a central role in the function of all cells and many 
viruses. Unlike most DNA and proteins, RNA interacts with other cellular molecules and 
biopolymers on both a sequence and structural level. RNA sequences act as the central 
information conduit in cells between the genome and ribosome, where genes are 
expressed as protein.1 Many cellular RNAs and RNA domains are not translated into 
proteins, but participate in events central to cellular and viral function. For example, 
RNA and RNA-protein conjugates play necessary roles in nearly all steps of protein 
production, including correct translation of gene sequences into proteins (mRNA, tRNA, 
and the ribosome1) protein localization (signal recognition particle2,3), and regulation of 
translation (riboswitches4, RNAi5). RNA also serves as the genomes of several viruses, 
including human immunodeficiency virus (HIV)6, hepatitis C virus7, influenza virus,8 and 
the virus that causes SARS9. Viral genomic RNAs represent genetic systems that contain 
both translated, mRNA-like regions, and domains that are not translated into protein. The 
noncoding domains are nonetheless critical for viral function.  
To accomplish these divergent tasks, RNA forms a variety of modular, 
intramolecular interactions that define catalytic active sites or modulate the function of 
regulatory motifs.12,13 RNA folds into structures that define binding sites for proteins, 
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metal ions, and small molecule ligands. Ligand binding may, in turn, cause a structural 
change in the RNA. For instance, RNA domains have been discovered that fold into 
structures that rearrange in the presence of a specific metabolite,4 thus modulating RNA 
function in response to cellular state. Other regions of RNA or entire RNA molecules 
may include long sequences with relatively little structure or exist as an equilibrium of 
different structures. These flexible regions may participate in, and reduce the energy costs 
of binding events, such as primer binding and dimerization.14  
Primary Sequence
Secondary Structure
Tertiary Structure
A
B
C
D
3-dimensional
structure
 
Fig. 1.1:  Hierarchical folding of S. cerevisae tRNA
Asp
. According to the 
hierarchical folding model, primary sequence (a) first forms base pairs or 
secondary structure (b). The secondary structure then forms tertiary interactions 
(c, dashed lines) to produce an active three-dimensional structure (d).
10,11
 
Nucleotides are colored for clarity. 
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Despite a few documented exceptions,15-17 current models indicate that RNA 
folding is strongly hierarchical (Figure 1.1)12 – that base pairing interactions (secondary 
structure) is more stable and forms more rapidly than tertiary interactions. This model 
indicates that formation of helices drives formation of tertiary structure by dictating 
which nucleotides are available for tertiary interactions.18 
1.1.1 Examples of RNA folding. Transfer RNA represents an instructive 
example of the different types of structures RNA can form. Four short helices are 
constrained in a specific three-dimensional conformation by a network of tertiary 
interactions, including coaxial helical stacks and base triples  (Figure 1.1 D).10,11 Folded 
tRNA molecules interact with aminoacyl tRNA synthetases which recognize specific 
tRNAs and charge them with specific amino acids,19 as well as with the ribosome and the 
mRNA sequence20. Folding of tRNA also plays a role in recognition by enzymes that 
covalently modify bases to more stringently enforce an active structure.21,22 
Large RNAs, such as the HIV-1 genome represent a more complex example of 
RNA folding. Large RNAs generally fold into a superstructure consisting of several 
different functional domains. Although only ~15% of the HIV-1 genomic structure has 
been rigorously characterized, a variety of structures for functional domains that 
recognize cellular and viral components have been proposed.6 For instance, the Tat and 
Rev viral proteins bind to specific secondary structures in the genome6. Tat enhances 
transcription of viral RNA; Rev participates in export of unspliced and singly-spliced 
genomes from the nucleus.23 The Tat binding site consists of a well-defined stem loop 
containing a three-nucleotide bulge.24,25 The Rev binding site (Rev-responsive element, or 
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RRE) also folds into an extensively paired structure, but competing secondary structural 
models have been proposed.26-28  
The HIV-1 genome contains structural domains that assist in dimerization and 
packaging of genomes into viral particles. Both steps are required for proper selection 
and export of infectious particles. The ! site, or packaging signal, is bound by the 
nucleocapsid domain of Gag and is targeted to the cell membrane for virion formation. 
This region also coincides with sequences implicated in the dimerization of the 
genome.6,29 Like the RRE, various different compact structures have been proposed for 
this region,29-36 but all indicate an extensive network of intramolecular interactions.  
The HIV-1 genome also forms structures that facilitate interactions with cellular 
components. To initiate reverse transcription, a single tRNALys3 binds a domain in the 
HIV-1 genome in as many as three different places.37 The binding site on the genome 
contains an enforced flexible region in the genome, as well as a stem-loop structure.32,33 
Cellular HIV transcripts also serve as a template for protein synthesis for cellular 
ribosomes. The cellular ribosome also recognizes a heptanucleotide slippery sequence as 
well as a specific RNA folding mode to effect a -1 nucleotide frameshift at the gag-pol 
gene junction. As with other regions of the HIV-1 genome, various different structural 
models, including a stem loop38 and pseudoknot39 have been proposed for the frameshift 
site.  
The HIV-1 genome folds into a structure with different structural domains 
designed to serve specific functions in the viral life cycle, including transcriptional 
activation, nuclear export, translation, and selection for packaging. Recent work has 
proposed structures for these domains, but the structures proposed are often incompatible 
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with one another, or miss elements other studies observe. A comprehensive view of the 
HIV-1 genome may be required to parse these models. 
 
1.2 Methods of analyzing RNA structure 
To explain the role of RNA structure in cellular function and disease, a number of 
chemical, physical, and computational methods are used to analyze the structure of RNA. 
Each method has yielded results that have been interpreted to develop well-supported 
models describing the function and structures of various important RNAs. X-ray 
crystallography40 is by far the best method for developing near-atomic resolution 
structures of highly structured regions of an RNA molecule and has been applied to 
RNAs and ribonucleoprotein complexes such as the entire ribosome41, RNAse P42, and 
the hairpin43 and GlmS44 ribozymes. These studies have provided enormous insight to the 
nature of RNA folding and catalysis.  
Nuclear Magnetic Resonance (NMR) has also been used to develop high-
resolution RNA structures in solution phase. NMR reports the dynamic nature of RNA in 
solution, but atomic resolution analysis is currently limited to RNA <100 long. This limit 
is due to the high degeneracy of the RNA molecule. Additionally, RNA has a relatively 
high tumbling rate in solution, which broadens linewidths.45,46 An important application 
of NMR technology is to analyze, in three dimensions, the dimerization and binding of 
RNA to various proteins and small molecule ligands. Crystallography and NMR provide 
atomic-resolution data but require comparatively large amounts of RNA and complicated 
data analysis.  
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When crystallographic or NMR approaches are not viable or unnecessary for an 
RNA of interest, a variety of nucleotide-resolution approaches have been developed that 
consume far less RNA and produce interpretable results with standard laboratory 
equipment. These techniques can also be used on RNAs that do not form stable, or well-
defined folds.  
Nucleotide-resolution probing approaches use chemicals or enzymes sensitive to 
local RNA structure to differentiate between constrained and flexible nucleotides. 
Reagents such as dimethyl sulfate (DMS), kethoxyl, bisulfite, diethyl pyrocarbonate 
(DEPC), and 1-cyclohexyl-3-(2-morpholinoethyl) carbodiimide metho-p-toluensulfate 
(CMCT) modify or cleave different subsets of flexible nucleotides in an RNA. Several 
RNase enzymes, such RNaseA, T1, and V1, preferentially cleave specifically at paired or 
single-stranded regions in an RNA.47,48 Structure sensitive cleavage with Pb2+49 and heavy 
metal complexes50 are additional common methods to identify RNA structure. Cleaved or 
modified sites on an RNA may be located using a number of separation and quantitation 
techniques, such as gel47 or capillary electrophoresis51 or mass spectrometry.52 These 
methods yield qualitative structural information at ~50 – 75% of nucleotides in an RNA 
especially when multiple reagents and enzymes are used in concert on the same RNA.  
An important application of the data developed by chemical and enzymatic 
techniques is to constrain RNA structure prediction algorithms. Most successful structure 
prediction algorithms use a thermodynamic model based on experimentally and 
heuristically determined constraints.53,54 However, thermodynamic models are 
approximate and non-thermodynamic contributions can modulate RNA structure. 
Therefore, de novo structure prediction may yield multiple structures whose accuracy 
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varies widely and can be quite low, especially for long sequences. Accuracy improves as 
constraints are incorporated into the prediction.55 Because chemical56 and enzymatic33 
probing methods leave gaps in structural information, some predictions remain open to 
misinterpretation or errors.57  
 
1.3 A robust method for RNA structure analysis 
With accurate RNA structures, it is possible to explain the functional bases of 
disease, describe basic mechanisms of life, and identify drug target sites.  
Crystallography, NMR, and chemical or enzymatic probing yield fair to excellent results 
that can be interpreted to develop structural models of entire RNAs or RNA motifs. 
However, the intrinsic properties of the extant technologies do not lend themselves to 
high-throughput approaches that can comprehensively analyze RNA structure. 
In collaboration with Edward Merino, I have developed a new technology, called 
selective 2’-hydroxyl acylation analyzed by primer extension, or SHAPE, that rapidly 
analyzes the structure of RNA of arbitrary length and structural complexity.57-60 SHAPE 
chemistry generates quantitative flexibility information for nearly all nucleotides in an 
arbitrary RNA. In this application the flexibility information is used as a guide for 
interpreting the state of base pairing or other structural constraints. 
One important application of SHAPE chemistry is to constrain structure 
prediction algorithms, such as RNAstructure, to predict RNA folds.55 SHAPE constraints 
applied to the RNAstructure program have been used to develop and confirm structural 
models or describe the structural effects of varying the state of an RNA.14,57-59,61 The 
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program correctly predicts ~90% of base pairs when applied to a well characterized 
RNA. Errors are usually short range and involve the nucleotides at the ends of helices.62 
Accurate structural constraints for RNA have a variety of additional applications 
aside from proposing RNA secondary structures. RNAi technology is a common 
approach used to silence gene expression in cells, and shows significant promise as a 
basis for viral, cancer, and genetic therapies.63,64 RNAi requires the efficient annealing of 
a RISC-RNA complex to a target mRNA.65 The location of these target sites in an RNA 
of unknown structure usually requires the use of time consuming screens.66-68 SHAPE 
chemistry, however, is ideally suited to locate flexible regions in RNA, which may 
represent available sites for RISC-mediated binding of RNAi, as well as other nucleotide 
ligands.69,70 
RNA often exists in cells bound to proteins as a ribonucleoprotein complex. 
Protein binding events on an RNA occlude and constrain various nucleotides; changes 
observable by SHAPE chemistry. Because SHAPE can be used in a complex solution, it 
is ideally suited to locate binding sites on an RNA and locate the structural changes that 
occur upon protein binding. Presently, SHAPE chemistry is being used to map protein 
binding on the telomerase RNA71 and the Saccharomyces cerevisiae bI3 intron splicing 
complex.72   
Structurally complex RNAs form native structure on the minute timescale or 
longer due to a complex energy landscape.73-75 The recent identification of fast acting 
chemicals that modify the 2'-hydroxyl opens the possibility of analyzing real-time folding 
of native RNAs.76 Characterization of intermediates in a folding pathway lends insight 
into the folding landscape of RNA and may also be used to develop the basis for more 
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powerful structure prediction algorithms that include kinetic as well as thermodynamic 
parameters.  
Folding and transcription may also be coupled resulting in native structures that 
may represent a local energy minimum. SHAPE chemistry could characterize folding 
intermediates during transcription by characterizing RNA libraries of the same sequence 
and different length. Fast acting reagents76 may also be used in concert with pulse-chase 
experiments to analyze folding intermediates during transcription. 
SHAPE chemistry can be applied to develop in vivo sensors. RNA aptamers are 
small RNA sequences that have been identified that bind small molecules77,78. These 
binding events often significantly change the structure of some nucleotides in the 
aptamer.79 Cells made to transcribe RNA aptamer sequences may be subjected to SHAPE 
chemistry. The structures determined by SHAPE can then be used to interpolate 
concentration of a small molecule in the cell. Significant groundwork has been completed 
for aptamers that bind ATP. Additionally, recent SHAPE-based data on tRNA folding 
indicates its potential use as an in vivo magnesium ion sensor.80 
The development of SHAPE technology required the modification or replacement 
of several steps in the traditional chemical modification techniques. Major innovations 
include identification of a chemical reaction that is generic to all 4 RNA nucleotides, 
development of a robust primer extension reaction that is insensitive to RNA structure, 
separation of products on a DNA sequencer, and development of software tools for 
quantitative, rapid analysis of the data. 
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1.4 Chapter overview 
 In this work, I describe the development of SHAPE chemistry from chemical 
observation to a generic method of RNA structure analysis. Chapter 2 explains the basic 
principles of the SHAPE technique. In collaboration with Edward Merino, we observe 
that the nucleophilicity of the RNA ribose hydroxyl is exquisitely sensitive to local 
nucleotide flexibility. We identify an electrophile, N-methylisatoic anhydride (NMIA) 
that preferentially modifies the 2'-oxyanion to form a 2'-O-ester adduct. This chemical 
observation is coupled with primer extension to measure adduct formation at all positions 
in an RNA. We use SHAPE to map the structure of and to distinguish fine differences in 
structure for tRNAAsp transcripts at single nucleotide resolution. I finish Chapter 2 with a 
practical guide for performing SHAPE chemistry, along with a troubleshooting manual. 
In chapter 3, I apply SHAPE chemistry to address the hierarchical RNA folding 
model to observe, for the first time, the unfolding of an RNA at single nucleotide 
resolution.18 With Edward Merino, I establish that SHAPE is an RNA analogue to the 
protein amide hydrogen exchange experiment, and that the NMIA-RNA reaction 
proceeds to identical endpoints independent of temperature. I perform equilibrium 
folding experiments on S. cerevisiae tRNAAsp and observe a complexity for the unfolding 
of tRNAAsp transcripts that is not anticipated by current models for RNA folding. We 
quantify six well-defined transitions for tRNAAsp transcripts between 35 and >75 ˚C, 
including asymmetric unfolding of the two strands in a single helix, multistep loss of 
tertiary interactions, and a multihelix conformational shift. The three lowest temperature 
transitions each involve coupled interactions between the secondary and tertiary 
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structure. Thus, even for this small RNA, multiple nonhierarchical and complex 
interactions dominate the equilibrium transitions most accessible from the native state. 
In Chapter 4, I describe the development of a high throughput SHAPE experiment 
(hSHAPE) in collaboration with Suzy Vasa, Rob Gorelick, Nicolas Guex, Alan Rein, 
David Mathews, and Morgan Giddings. I describe adaptation of SHAPE to a DNA 
sequencer. DNA sequencers can analyze SHAPE data for longer RNAs – up to 500 
nucleotides in a single read, and require less time and effort than gel electrophoresis. I 
also describe a number of software innovations, made in collaboration with Suzy Vasa 
and Nicolas Guex, that allows rapid and quantitative analysis of SHAPE data from a 
DNA sequencer. I will also describe some techniques useful in developing structural 
models from hSHAPE data. 
In chapter 5, I collaborate with Robert Gorelick, Suzy Vasa, Nicolas Guex, Alan 
Rein, David Mathews, and Morgan Giddings to use hSHAPE to comprehensively analyze 
the 5'-most 10% of the HIV-1 genome under four different states, including authentic 
virions– a structural analysis of over 8200 nucleotides. Virion-specific structures and 
protein binding sites are analyzed by comparison with protein-free genomic RNA and 
authentic RNAs in which native protein interactions are disrupted. Despite a large 
number of thermodynamically accessible states, the 5'-end of the HIV-1 genome exists in 
a single predominant conformation. I observed that untranslated regulatory domains are 
more highly structured than coding regions. I detected two opposing activities for the 
HIV nucleocapsid protein.  Stable nucleocapsid-RNA interactions occur at multiple, 
newly defined, motifs in a regulatory domain; conversely, nucleocapsid destabilizes local 
RNA structure specifically at sites required to undergo conformational rearrangements, 
 12 
including the region where reverse transcriptase initiates cDNA synthesis. This chapter 
reveals a complex coupling between the HIV-1 genome structure and function. The last 
two chapters also lay the groundwork for comprehensive, quantitative analysis of any 
viral and cellular RNA. 
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CHAPTER 2 
 
PRINCIPLES OF SHAPE CHEMISTRY 
 
2.1 Introduction 
SHAPE technology is divided into two overarching steps. In the first part, RNA is 
sparsely modified at the 2’-hydroxyl position in a structure-selective manner. Next, sites 
of modification are located by a carefully optimized primer extension. The extent of 
modification is then quantified at all positions in an RNA. Some aspects of the SHAPE 
strategy have similarities to classical chemical modification experiments, but advantages 
of SHAPE are that it is (i) rapid, (ii) quantitative, and (iii) reacts similarly with all 4 
nucleotides.1,2 In this chapter, I describe, in depth, the underlying principles of SHAPE – 
the nature of the structure-sensitive chemistry, and innovations in primer extension. I 
include a stepwise procedure for a generic SHAPE experiment with troubleshooting 
advice at the end of this chapter.  
2.1.1 The 2'-position is a candidate for structure-sensitive chemistry. The 2'-
ribose position (Figure 2.1) presents an appealing chemical target as it is both accessible 
for chemistry, and generic to all 4 nucleotides. In collaboration with Edward Merino, I 
characterized a reagent that targets the 2'-hydroxyl in a structure-selective manner and 
propose a model for 2'-hydroxyl reactivity in flexible and paired nucleotides. We applied 
this observation to map, at single nucleotide resolution, the structure of a model RNA. 
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2.1.2 Previous studies on the 2'-ribose 
position. Previous work on the 2'-ribose position 
indicated that its reactivity is strongly modulated by 
the adjacent 3'-phosphodiester anion.3,4 Acylation of 
synthetic 2'-amine substituted nucleotides to form a 
2'-amide product is strongly gated by the underlying 
local nucleotide flexibility.3,5-8 Flexible nucleotides 
in RNA are better able to reach a facilitated 
transition state in which the 3'-phosphodiester 
becomes appropriately positioned with the 2'-amine 
to exert a catalytic effect.4 2'-amine acylation thus 
robustly detects essentially all base paired RNA 
secondary structures and many tertiary interactions 
when the sites of 2'-adduct formation are mapped by primer extension.3,7  
2'-amine-based chemistry is significantly more straightforward to implement than 
traditional chemical or enzymatic approaches for monitoring RNA secondary and tertiary 
structure. However, introduction of an artificial 2'-amine group makes an experiment 
more complex, prevents this chemistry from being used in vivo, and may perturb some 
tertiary interactions involving the 2'-ribose position.  
We considered that the proximity of a 3'-phosphodiester anion might modulate the 
reactivity of the 2'-hydroxyl group normally present in RNA. Since every nucleotide has 
a 2'-hydroxyl, structural information is, in principle, obtainable for every position in an 
 
Fig. 2.1: A generic RNA 
helix. The 2'-hydroxyl group 
(blue spheres) lie on the 
sugar-phosphate backbone 
and are solvent accessible. 
The aromatic bases (green) 
are sequestered inside of the 
helix. 
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RNA. Formation of a bulky 2'-O-adduct could then be detected as an impediment to 
cDNA synthesis by reverse transcriptase.3,7  
2.1.3. Identification of a 2'-hydroxyl reactive reagent. Since prior work 
indicates that the nucleophilicy of a 2'-ribose substituent is modulated by the proximal 3'-
group,4 we sought to identify a small molecule reagent that modified the 2'-hydroxyl 
under diverse environments. The most promising reagent was N-methylisatoic anhydride 
(NMIA) which liberates CO2 to form a 2-methylaminobenzoic acid nucleotide-2'-ester 
under mild, aqueous conditions2,9,10 (Figure 2.2A). NMIA specifically reacts with the 
ribose position in nucleotides, as monitored by gel shift assays using small nucleotides.2  
A reagent that is capable of modifying hydroxyl groups in aqueous solution will 
be subject to a competing hydrolysis reaction. NMIA degrades to 2-
methylaminobenzoate with experimentally tractable rates over a range 25˚ to 75˚ C.1,2 
(Figure 2.2 B and C). Careful measurement of the rates of hydrolysis allows calculation 
of the rates for ribose 2'-O-adduct formation.1  
2.1.4 NMIA reactivity with nucleotides is modulated by the 3'-substituent. 
Attack of a 2'-hydroxyl at the anhydride moiety of NMIA requires formation of the 
significantly more nucleophilic 2'-oxyanion prior to reaching the ester-forming transition 
state (see first step in Figure 2.2). Formation of the 2'-oxyanion would be destabilized if 
the negatively charged 3'-phosphodiester were constrained to be adjacent to the 2'-
position (see red overlap symbols in Figure 2.2). Because formation of the oxyanion 
involves loss of a proton, the hydroxyl pKa is a good indicator for the relative 
nucleophilicity of a 2'-hydroxyl. The pKa for deprotonation of the 2'-hydroxyl of 
adenosine is 12.2, and this pKa increases to 13.4 for adenosine 3'-phosphate.
11 The 
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 relative nucleophilicity of a 2'-hydroxyl is thus strongly modulated by neighboring 
functional groups at the 3'-position. Formation of the oxyanion also presumably induces 
secondary changes in ribose conformation to yield complex relationships between 
nucleotide structure and the 2'-hydroxyl pKa.  
 
 
Fig. 2.2: Reaction of a ribose 2'-hydroxyl with NMIA via formation of an oxyanion 
nucleophile. (A) Nucleotides constrained in the RNA C3'-endo and other conformations 
are unreactive due to destabilization (red overlap symbol) of the oxyanion by the 
proximal 3'-phosphodiester. (B) Reaction of NMIA with water to form 2-
methylaminobenzoate. (C) Hydrolysis half life of NMIA as a function of temperature. Half 
lives follow a single exponential as a function of temperature. 
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To test this model, a series of analyses were carried out using an instructive set of 
small nucleotides that contained 3'-substituents of different size and charge.2 These 
studies indicated that NMIA requires a free 2'-hydroxyl group to modify RNA and that 
the reactivity of a ribose hydroxyl group is decreased by the proximity of any phosphate 
group. Reactivity can be recovered either by replacing a phosphate diester with an 
uncharged analog or by increasing the distance between the hydroxyl and phosphate 
groups.  
2.1.5 Structure-selective 2'-hydroxyl reactivity in an oligonucleotide. These 
studies on the relationship between constrained local structure and 2'-hydroxyl reactivity 
were extended by evaluating reactivity in an 11-mer oligonucleotide.2 This RNA was 
synthesized with a 5'-monophosphate radiolabel and a 3'-dideoxycytidine nucleotide so 
that all 10 remaining hydroxyl groups lie in internal linkages and adjacent to 3'-
phosphodiester groups.  
When we exposed this oligonucleotide to NMIA under mild conditions, we could 
observe the formation of product by gel shift assay. Rates of 2'-O-adduct formation were 
comparable to small nucleotide analogs of flexible RNA, supporting the interpretation 
that small nucleotide analog studies reproduce key features of 2'-O-adduct formation. 
When the 11-mer oligonucleotide was hybridized to its complement, the rate of 
adduct formation decreased by 10-fold.2 Residues at RNA helix termini can experience 
fraying,12,13 making them more flexible than internal nucleotides. Therefore nucleotides 
imbedded within long helices most likely have a far lower reaction yield than that 
measured here. The 2'-hydroxyl groups in RNA helices project outward towards the 
solution (Figure 2.1). Therefore, the differential reactivity of single-stranded versus  
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duplex RNA rules out solvent 
accessibility as the primary 
explanation for structure-sensitive 
2'-hydroxyl reactivity. 
Studies with small 
nucleotide analogs as well as an 11-
mer model RNA indicated that 
NMIA is a good candidate to 
interrogate the structure of RNA. 
Three main observations support 
this conclusion: (i) NMIA 
specifically modifies the 2' position 
of RNA, which is generic to all 4 
nucleotides, (ii) NMIA hydrolyzes 
under an experimentally tractable 
timescale, making a quench 
unnecessary, and (iii) NMIA scores 
nucleotide flexibility, not solvent 
accessibility. 
2.2 Results 
2.2.1 A structure cassette 
for analyzing tRNA
Asp
 
conformation. We applied selective 
 
Fig 2.3. tRNA
Asp
 transcript in the context of an 
RNA structure cassette. tRNAAsp structure is 
drawn to suggest orientation of helices and tertiary 
interactions in three-dimensional space. Tertiary 
interactions are indicated by dashed lines in gray. 
5' and 3' linker regions facilitate analysis of sites of 
2'-O-adduct formation by primer extension and 
have been shown to fold independently of the 
internal tRNA structure.2 By convention,14,15 
nucleotides in yeast tRNAAsp are numbered 1-76, 
with residue 47 omitted. 
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2'-hydroxyl acylation analyzed by primer extension (SHAPE) to explore the structure of 
S. cerevisiae tRNAAsp transcripts. The well studied L-shaped tRNAAsp structure3,14-17 
(Figure 2.3A) encompasses interactions that comprise any folded RNA including double-
stranded helices, single-stranded loops and connecting regions, and a network of tertiary 
interactions. The secondary structure shown (Figure 2.3A) emphasizes the three-
dimensional fold of the RNA in which (i) the anticodon and D-stems and (ii) the acceptor 
and T-stems stack. These two pairs of coaxially stacked helices are then held together in 
the tRNA architecture by tertiary interactions between the D- and T-loops and involve the 
joining regions at positions U8-A9 and G45-U48. 
The tRNAAsp transcript was placed in the center of an RNA “structure cassette” to 
facilitate analysis of 2'-O-adduct formation by primer extension (Figure 2.3B). Each 
stem-loop structure in the cassette contains a stable UUCG tetraloop18,19 to enforce the 
designed fold and eliminate alternate foldings with tRNAAsp. The hairpins that comprise 
the flanking 5' and 3' cassette structures have three functions. (i) The 3'-most sequence 
(green in Figure 2.3B) provides the DNA primer binding site required to initiate reverse 
transcription. (ii) The 3'-linker (blue) between the primer binding site and the first 
position in the tRNA allows the reverse transcriptase enzyme to become fully processive 
prior to reaching the region of structural interest. This linker also prevents non-templated 
primer extension products from masking structural information at the 3' end of the RNA. 
(iii) The 5' portion of the cassette (red in Figure 2.3B) displaces the abundant full-length 
extension product that would otherwise obscure structural information at the 5' end of the 
RNA. Overall, the design of the structure cassette balances the requirements that it fold 
autonomously, not interact with the internal RNA, and efficiently bind a primer DNA. 
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2.2.2 SHAPE footprinting of tRNA
Asp
. The tRNAAsp construct was folded under 
conditions that strongly favor formation of the native conformation (100 mM NaCl, 10 
mM MgCl2)
3,16,17 at 35 °C. NMIA was added and allowed to react with the RNA for 5 
hydrolysis half lives (54 min). Sites of 2'-esterification (Figure 2.2) were identified as 
stops to primer extension by reverse transcriptase. The presence of a 2'-O-adduct causes 
the reverse transcriptase to stop exactly one nucleotide prior to the modified base.  
Primer extension products were resolved in a sequencing gel and converted to 
intensity versus position plots (Figure 2.4A). When tRNAAsp was incubated under the 
standard reaction conditions in the absence of NMIA, primer extension yielded a strong 
full-length product and only minor bands of intermediate length (green trace, Figure 
2.4A). When an otherwise identical SHAPE experiment was performed in the presence of 
NMIA, a strong and reproducible pattern of 2'-O-adducts was detected by primer 
extension [compare black (+ NMIA reaction) with green (– NMIA) traces in Figure 
2.4A]. The fraction of full-length extension product was 70% of that for the no reaction 
control, indicating that NMIA reacts with single-hit kinetics.20 Sites of adduct formation 
were identified by comparison with a dideoxy sequencing lane (blue trace, Figure 2.4A). 
Regions that showed the strongest reactivity relative to background are 
emphasized with red bars in Figure 2.4A and all reactivities are superimposed on a 
secondary structure for the RNA transcript in Figure 2.4B. Comparing the most reactive 
nucleotide, U33 in the anticodon loop, with unreactive residues in, for example, the T- 
and acceptor stems indicates that the dynamic range of the SHAPE experiment spans 30-
50 fold. 2'-Hydroxyl reactivity observed in the 5' and 3' linkers is exactly that expected 
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for proper folding of the cassette, indicating the structure cassette folds as designed 
(Figure 2.4B). 
When superimposed on the secondary structure for tRNAAsp and the flanking 
structure cassette, absolute 2'-hydroxyl reactivities correspond closely to whether or not a 
given nucleotide is constrained. Nucleotides that do not participate in either base pairing  
or a tertiary interaction are most reactive (red and orange columns in Figure 2.4B). 
 
 
Fig. 2.4. SHAPE analysis of tRNA
Asp
. (A) Profile for 2'-O-adduct formation as a function of 
nucleotide position, visualized by primer extension. Reactions performed in the presence 
and absence of NMIA are shown in black and green, respectively. Regions that react 
selectively with or are excluded from reaction with NMIA are emphasized with red or green 
bars, respectively. A dideoxy sequencing marker is shown in blue and is 1 nucleotide 
longer than corresponding positions in the (+) and (–) NMIA lanes. (B) Absolute 2'-hydroxyl 
reactivities superimposed on a secondary structure for the tRNAAsp construct. Column 
heights are proportional to the band intensities shown in part A (black trace) minus 
background. (C) SHAPE reactivities superimposed on the crystal structure of tRNAAsp.14,15 
The phosphate-sugar backbone is colored according to SHAPE reactivity. The color 
scheme is the same as that in Figure 2.4B. 
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Conversely, NMIA modification is significantly reduced in each of the structures that  
comprise the four canonical tRNA helices (green, blue and black columns in Figure 2.4B, 
green, blue, and black colors, Figure 2.4C). Tertiary interactions including interaction of 
G45 with the G10:U25 pair, the A15:U48 Levitt pair, the A14:A21:U8 base triple, and 
the U54:A58 intraloop interaction are unreactive. 
2'-Ribose-based NMIA chemistry is clearly generic to all RNA nucleotides. Each 
nucleotide (A,G,C,U) shows strong reactivity in at least one part of the tRNAAsp 
transcript and all four nucleotides show protection at other positions when constrained by 
base pairing or a tertiary interaction (Figure 2.4B, see Figure 2.3A for nucleotide 
assignments) 
 
2.3 Discussion 
2.3.1 2'-Hydroxyl acylation with NMIA scores local nucleotide flexibility. 
RNA SHAPE footprinting reproduces the canonical structure of tRNAAsp. Reactive 
nucleotides lie almost exclusively in the conserved T-, D- and anticodon loops and at the 
3'-CCA terminus (red and orange colors in Figures 2.4B and C). Of the five non-
canonical G-U or G-A pairs in tRNAAsp, only one, in the anticodon stem, is reactive. 
SHAPE footprinting thus appears to be more sensitive to constraints imposed by non-
canonical pairing than traditional chemistries because G-U and G-A pairs are typically 
reactive toward DMS and CMCT.16,17,21 
NMIA reactivity also detects tertiary interactions. Essentially all nucleotides that 
form higher order interactions (dashed lines in Figure 2.4B) are unreactive at 35 °C. This 
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is a striking result given that the unreactive structures are constrained by diverse local 
tertiary interactions including Hoogsteen paring, base triples, and cross-loop interactions. 
Finally, the SHAPE approach is also uniquely information-rich in the sense that 
the absolute reactivity amplitudes appear to be meaningful. First, nucleotides in the T- 
and D-loops, while generally reactive, are less so than those in the anticodon loops, 
consistent with formation of significant tertiary interactions in the former loops. Within 
the T-loop, the cross-loop U54-A58 interaction is reported by low reactivities in an 
otherwise reactive region. Second, nucleotides in the C-G rich T- and acceptor stems 
show measurably lower reactivities than many nucleotides in the D- and anticodon stems 
(Figure 2.4B and C). Third, inspection of the local patterns of reactivity within each of 
the loops in tRNAAsp, at the 3'-CCA region, and in the 3'-cassette (the +10  to +14 loop) 
shows a reproducible trend in which the center-most loop nucleotides are more reactive 
than nucleotides that abut constrained positions in the adjacent duplexes. These data 
together emphasize that SHAPE mapping reveals significant fine gradations in local 
nucleotide flexibility. 
2.3.2 NMIA modification does not score solvent accessibility. We compared 
the relative reactivities obtained by SHAPE with calculated molecular surface areas at the 
ribose 2'-position, assuming a solvent-sized probe and using the crystallographic 
coordinates 14,15 for tRNAAsp (Figure 2.5). Consistent with the results obtained with the 
11-mer oligonucleotide,2 2'-O-adduct formation in tRNAAsp does not correlate with 
solvent accessibility. For example, the entire anticodon stem and loop structures, 
spanning nucleotides 26-44, have generally high solvent accessibility (! 20 Å2 per ribose 
2'-O atom) but feature both unreactive and highly reactive positions (compare gray bars 
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with black line in Figure 2.5). Analogously, both the D- and T-loops include residues 
with low calculated static solvent accessibility but high 2'-hydroxyl reactivity; 
conversely, the acceptor and T-stems (positions 49-53 and 60-72) are solvent accessible 
but unreactive (Figure 2.5). 2'-Hydroxyl reactivity is thus not correlated with static 
solvent accessibility, strongly supporting models (Figure 2.2) that emphasize local 
conformational changes as the primary determinant of 2'-hydroxyl reactivity. 
We also compared SHAPE with chemical mapping experiments 16,17 employing 
the traditional base-reactive reagents, dimethyl sulfate (DMS) and diethylpyrocarbonate 
(DEPC). The correlation between nucleotides reactive by SHAPE and with DMS and 
DEPC is very strong (compare gray bars and filled circles in Figure 2.5). This is a 
striking conclusion considering that DMS and DEPC react largely at nucleophilic 
positions in purine bases 22 while NMIA reacts at the RNA backbone and strongly 
supports the model (Figure 2.2) that local nucleotide flexibility is the primary 
 
Fig. 2.5. RNA SHAPE reactivity is not correlated with solvent accessibility. Relative 2'-
O-adduct formation (gray bars) were calculated from the data shown in Figure 2.4A. 
Solvent accessibilities (heavy lines) were computed assuming a probe radius of 1.4 Å. For 
comparison, results from chemical mapping studies on tRNAAsp transcripts using DMS and 
DEPC16 are shown with spheres; reactive and unreactive positions are emphasized with 
filled and open spheres, respectively. 
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determinant for reactivity by SHAPE chemistry. The major difference occurs at position 
68, where the guanosine residue in a G-U pair is reactive towards DMS, but not with the 
more selective SHAPE chemistry (Figure 2.5). 
The direct comparison between traditional and SHAPE chemistries also 
emphasizes important advantages of SHAPE. First, all nucleotides are interrogated in a 
single reaction so there are no or fewer regions lacking structural information. Second, 
instead of simply classifying positions as reactive or not, SHAPE lends itself naturally to 
quantitative analysis (Figures 2.4B and 2.5). 
2.3.3 2'-Ribose chemistry, local nucleotide flexibility, and the influence of the 
3'-phosphodiester anion. Reaction of 2'-hydroxyl groups (Figure 2.6A) and of 2'-amine 
substitutions (Figure 2.6B) in RNA to form ester or amide linkages, respectively, are both 
strongly sensitive to local nucleotide flexibility (Figure 2.4B and references 1 and 4). We 
postulate that the physical basis for this effect in both cases stems predominantly from the 
influence of the proximal 3'-phosphodiester anion on reactivity at the 2'-position. The 
contribution of the 3'-phosphodiester potentially includes direct charge-charge 
electrostatic effects, differential hydrogen bonding, changes to the pKa of the 2'-group, 
and generalized electrostatic and dielectric effects in the local environment.  
However, the detailed reaction pathways for the 2'-ester versus the 2'-amide 
forming reactions are quite different. Reaction of a 2'-hydroxyl to form a 2'-ester 
proceeds via formation of an oxyanion in a pre-equilibrium step (Figure 2.2) and yields 
negative charge on the nucleophile in the transition state (Figure 2.6A). In contrast, 2'-
amide formation involves direct attack of the unperturbed, 2'-NH2 form 
4,23 of the 
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nucleophile and a transition state in which there is a partial positive charge on the amine 
nucleophile (Figure 2.6B). 
 
A proximal 3'-phosphodiester anion thus destabilizes formation of the 2'-oxyanion 
formed in a pre-equilibrium step (see interference symbol in Figure 2.6A), but stabilizes 
the amine nucleophile (dashed green line in the transition state in Figure 2.6B). These 
contrasting effects are supported directly by nucleotide analog studies2,3 and especially by 
 
 
Fig. 2.6. Distinct contributions of the 3'-phosphodiester anion for reaction of a 
flexible (gray arrows) ribose 2'-hydroxyl versus 2'-amine. Reaction pathways for (A) 2'-
hydroxyl and (B) 2'-amine acylation. (C,D) relative reactivities of cAMP analogs. Reference 
dinucleotides were pA2'-OHp-ddC2 and pU2'-NH2pU,2,4 respectively. 
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cAMP analogs, which constrain the 3'-phosphodiester anion to be distant from a 2'-
hydroxyl or 2'-amine nucleophile. Because the 3'-phosphodiester group electrostatically 
destabilizes the 2'-oxyanion, cAMP reacts (18-fold) faster than a reference dinucleotide 
(Figure 2.6C). In contrast, reaction of the 2'-amine, whose transition state is stabilized by 
the proximal anion, becomes undetectable (at least 30-fold slower) for 2'-amino-cAMP 
(Figure 2.6D). Flexible nucleotides sample a broad ensemble of conformations (gray 
arrows in Figure 2.6). Distinct constellations are able both to minimize the electrostatic 
influence of the 3'-phosphodiester and facilitate 2'-oxyanion formation or, alternately, to 
align the 3'-group and to facilitate the amide-forming transition state. 
 In summary, the nucleophilicity of the 2'-position in the context of an RNA 
nucleotide is gated by a complex energy landscape. Factors such as formation of proton 
resonance structures, distance between the 2'-position and the 3'-phosphate, and 
electrostatic effects all play a role in influencing the intrinsic reactivity. In the case of 
both 2'-amino RNA and unmodified RNA, constrained nucleotides do not sample 
conformations that enhance nucleophilicity. However, flexible nucleotides sample 
conformations that both enhance and reduce nucleophilicity. Therefore, on average, the 
reactivity of flexible nucleotides is higher than constrained nucleotides.  
  
2.4 Perspective  
SHAPE mapping takes advantage of the strong linkage between reactivity at the 
2'-hydroxyl position and destabilization of nucleophilic chemistry at this site by the 
adjacent 3'-phosphodiester anion (Figures 2.2, 2.6 and reference 4). SHAPE footprinting 
affords a comprehensive view of nucleotide-resolution base pairing and tertiary 
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interactions in an RNA: nearly all nucleotides are interrogated in a single experiment. 
(Figure 2.4). SHAPE reactivity amplitudes also measure quantitatively subtle differences 
in the degree to which a given nucleotide is constrained. RNA structure mapping 
chemistries based on reaction at the 2'-hydroxyl have made possible facile nucleotide 
resolution analysis of RNA as a function of ion environment, temperature, ligand 
binding, and conformational switches. 
 
2.5 A step-by-step guide to SHAPE chemistry 
 
2.5.1 Requirements of SHAPE chemistry. The material requirements for a 
SHAPE experiment are modest.2 A complete experiment requires 3-4 pmol of RNA. 2 
pmol are required for the SHAPE chemistry itself and 1 pmol is required for each 
sequencing experiment used for band assignment. One or two sequencing experiments 
are usually sufficient. RNAs of any length are appropriate substrates for SHAPE, as long 
the RNA has no post-transcriptional modifications or unusually stable secondary 
structures that prevent its functioning as a template for primer extension. NMIA 
modification works well under a wide variety of solution conditions, ionic strength, and 
temperatures. SHAPE results have been obtained under a wide variety of chemical 
conditions and temperatures. Good results are obtained at 0-200 mM monovalent ion 
(NaCl, KCl or potassium acetate), 0-40 mM MgCl2, and 20-75 °C (Figure 2.2C). In fact, 
titrations of magnesium and temperature using SHAPE chemistry have revealed complex 
structural rearrangements.1,24 
In addition, an RNA may be modified in the presence of protein or other small 
and large biological ligands. Solution components that react directly with NMIA as well 
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as organic co-solvents, including formamide and DMSO, are well tolerated but may 
require that reagent concentrations be adjusted. NMIA reactivity is strongly dependent on 
pH; thus, the major experimental restriction is that the pH be maintained close to 8.0. In 
practice, pH values of 7.5–8.2 work well. The dynamic range that differentiates the most 
reactive (flexible) and least reactive (constrained) nucleotides typically spans a factor of 
20-50. 
2.5.2 RNA design. Because SHAPE reactivities are assessed in a primer 
extension reaction, information is lost at both the 5' end and near the primer binding site 
of an RNA. Typically, the 10-20 nucleotides adjacent to the primer binding site cannot be 
quantified due to the presence of cDNA fragments that reflect pausing by the reverse 
transcriptase enzyme during the initiation phase of primer extension. The 8-10 positions 
at the 5' end of the RNA also cannot be visualized due to the presence of the intense band 
corresponding to the full-length extension product. 
 To monitor SHAPE reactivities at the 5' and 3' ends of an sequence of interest, the 
RNA can either be (i) embedded within a larger fragment of the native sequence or (ii) 
placed between strongly folding RNA sequences that contain a unique primer binding 
site.2 We have designed a structure cassette (Figure 2.3B) that contains 5' and 3' flanking 
sequences of 14 and 43 nucleotides and allows all positions within the RNA of interest to 
be evaluated in a sequencing gel. Both 5' and 3' extensions fold into stable hairpin 
structures that do not appear to interfere with folding of diverse internal RNAs.2,25 The 
primer binding site of this cassette efficiently binds to a cDNA primer (Figure 2.3B). The 
sequence of any 5' and 3' structure cassette elements should be checked to ensure that 
they are not prone to forming stable base pairing interactions with the internal sequence. 
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2.5.3 RNA folding. The SHAPE experiment is most commonly performed with 
RNAs that have been generated by in vitro transcription.2,25,26 These RNAs require 
purification by denaturing gel electrophoresis and then must be renatured to achieve a 
biologically relevant conformation. This protocol describes a simple approach that works 
well for renaturing many RNAs. However, any procedure that folds the RNA to the 
desired conformation at pH 8 can be substituted. The RNA is first heated and snap cooled 
in a low ionic strength buffer to eliminate multimeric forms. A folding solution is then 
added to allow the RNA to achieve an appropriate conformation and to prepare it for 
NMIA modification. The RNA is folded in a single reaction and is later separated into (+) 
and (-) NMIA reactions.  
2.5.4 RNA modification. NMIA is added to the folded RNA to yield 2'-O-
adducts at flexible nucleotide positions. The reaction is then incubated until essentially all 
of the NMIA has either reacted with the RNA or has degraded due to hydrolysis with 
water (see Figure 2.2). No specific quench step is required. The modified RNA is 
precipitated with ethanol in order to purify the RNA from reaction products and buffer 
components that may be detrimental to the primer extension reaction. 
2.5.5 Primer extension. Although analysis of RNA adducts by primer extension 
is widely considered to be problematic, we find that the optimized experiment described 
here works well for most RNAs. Key innovations include use of an optimized primer 
binding site (Figure 2.3), thermostable reverse transcriptase enzyme, low [MgCl2], 
elevated temperature, and short extension times. It is also essential to use intact, non-
degraded RNA, free of reaction by-products and other small molecule contaminants. 5'-
radiolabeled DNA primers are annealed to the RNA and then extended to sites of 
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modification in the presence of dNTPs by the activity of reverse transcriptase. The RNA 
component of the resulting RNA-cDNA hybrids is degraded by treatment with base. The 
cDNA fragments are resolved on a polyacrylamide sequencing gel. 
2.5.6 Sequencing. Sequencing lanes generated by dideoxy nucleotide 
incorporation are used to assign bands in the (+) and (–) NMIA lanes. One or two 
sequencing reactions is usually sufficient to infer the entire sequence. These steps are 
conveniently performed concurrently with the primer extension reactions for the (+) and 
(–) NMIA tubes.  
2.5.7 Reagents and materials. All reagents as well as reaction tubes and 
equipment must be maintained free of RNase contamination. For best results, all 
chemicals should be purchased at the highest quality available and reserved for RNA use 
only.  
3.3! RNA folding mix (333 mM HEPES-NaOH, pH 8.0, 20 mM MgCl2, 333 mM NaCl). 
Other conditions that are known to stabilize the functional structure of the RNA under 
study can be used as well. Both buffering component and ionic strength can be varied. 
In the modification reaction, buffer concentration should be at least twice the NMIA 
concentration and adjusted to pH 8. 
10! NMIA in DMSO. The recommended concentration of this solution varies with RNA 
length. For RNA reads of 100, 200 and 300 nucleotides, 10! NMIA 
concentrations of 130, 65 and 30 mM, work well. Due to the solubility of the 
reagent, the stock concentration of NMIA should not be greater than 130 mM. 
SHAPE enzyme mix (250 mM KCl, 167 mM TRIS-HCl, pH 8.3, 1.67 mM each dNTP, 
17 mM DTT, 10 mM MgCl2). The enzyme mix may be prepared by combining 4 
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parts SSIII FS Buffer , 1 part 0.1 M DTT, and 1 part 10 mM dNTP mix (10 mM 
in each deoxynucleotide; This solution is stable for months at –20 ˚C but is 
intolerant of freeze-thaw cycles. Maintaining small aliquots at –20 °C is 
recommended.) 
5'-[32P]-Labeled Primers. These are prepared by performing the following steps: (1) Mix 
the following well: 1 µL 60 µM DNA primer, 16 µL "-[32P]-ATP, 2 µL 10! PNK 
buffer, and 30 units27 (1 µL) T4 Polynucleotide Kinase. (2) Incubate at 37 °C for 
30 min. (3) Purify on 20% denaturing polyacrylamide gel (1! TBE, 7 M urea). 
Use autoradiography to visualize and excise the band corresponding to the 
radiolabeled DNA primer. (4) Passive elute overnight into water and remove 
small pieces of acrylamide from the RNA using a centrifugal filter device. (5) 
Recover radiolabeled DNA by ethanol precipitation (see step 8 of the 
PROCEDURE). (6) Dissolve the pellet in 100 µL 1 mM HEPES-NaOH, pH 8.0. 
The final primer solution concentration is ~ 0.3 µM. 
2.5.8 Stepwise procedure for a SHAPE experiment. 
1 Add 2 pmol RNA in 12 µL 0.5! TE (5 mM Tris-HCl, pH 8, 0.5 mM EDTA, pH 
8) to a 200 µL thin-walled PCR tube. 
2 Heat the RNA to 95 °C for 2 min; then, immediately place the RNA on ice for 2 
min. 
3 Add 6 µL folding mix and mix solutions by gentle repetitive pipetting. 
4 Remove the tube from ice and incubate at the desired reaction temperature for 20 
min in a programmable incubator. 37 °C is a good initial choice. 
 40 
5 While the tube is incubating, remove 9 µL and place it in a second tube. One tube 
will be used for the (+) NMIA reaction, the other for the (–) NMIA reaction.  
6 Add 1 µL of NMIA in DMSO to the (+) NMIA tube and 1 µL of neat DMSO to 
the (–) NMIA tube and mix well. Some initial turbidity in the tube is normal, 
especially when working at high NMIA concentrations.  
7 Incubate the reaction for five NMIA hydrolysis half-lives. To estimate the NMIA 
half-life between 15 and 75 °C , use the empirical equation:  
half-life (min) = 360 ! exp[–0.102 ! temperature (°C)]  (2.1) 
At 37 °C, NMIA has a half-life of 8.3 min; therefore, at 37 °C, the reaction should 
be incubated for ~45 min. 
8 After the reaction has gone to completion, transfer reactions to 1.5 mL centrifuge 
tubes, and recover the modified RNA by ethanol precipitation: (i) Add 90 µL 
water, 4 µL 5 M NaCl, 1 µL 20 mg/mL glycogen, and 350 µL absolute ethanol. 
(ii) Incubate at –80 °C for 30 min. (iii) Sediment the RNA by spinning at 
maximum speed in a microfuge at 4 °C for 30 min. Perform step 10(ii) during this 
centrifugation. 
9 Remove ethanol supernatant; redissolve RNA in 10 µL of 0.5! TE and transfer 
samples to 200 µL thin-walled PCR tubes.  
10  (i) Add 3 µL radiolabeled primer solution to the (+) and (–) NMIA tubes. Mix by 
repetitive pipetting. (ii) To sequence the RNA for assigning bands in the (+) and 
(-) NMIA samples, add 3 µL of primer solution to 1 pmol of RNA in 8 µL 0.5! 
TE.  
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11 Anneal the primer to the RNA by incubating tubes at 65 °C for 5 min and then at 
35 °C for 5 min.  
12 Add 6 µL of SHAPE enzyme mix to the (+) and (–) NMIA reactions. To each 
sequencing experiment, add one ddNTP solution (1-2 µL, 10 mM) as well. 
13 Heat the tubes to 52 °C for 1 min. 
14 Add 1 µL of Superscript III to each tube. Mix well by gentle repetitive pipetting. 
Immediately return the tube to the heat block.  
15 Incubate tubes at 52 °C for 10 min.  
16 Add 1 µL 4M NaOH. This degrades the RNA but does not damage DNA. 
17 Heat the samples to 95 °C for 5 min. 
18 Add 29 µL of acid stop mix. 
19 Incubate at 95 °C for 5 min.  
20 Load (+) NMIA, (–) NMIA, and sequencing reactions in individual lanes of a 
polyacrylamide sequencing gel (29:1 acrylamide:bis acrylamide, 1! TBE, 7 M 
urea). Load ~2 µL per lane. For extensions of 100 or fewer nucleotides, perform 
electrophoresis for 150 min at 70 W. To visualize RNA extension reactions 
spanning more than 100 nucleotides, re-load samples after 150 min in unoccupied 
lanes on the gel and continue electrophoresis for an additional 150 min at 70 W. 
The sample loaded first will have been subjected to electrophoresis for ~300 min, 
yielding well-resolved positions near the 5' end of the RNA. 
21 Expose the gel overnight to a phosphor screen and quantify scanned bands using a 
phosphorimaging instrument. Quantify the intensity of every well-defined band in 
the gel for the (+) and (–) NMIA lanes by two-dimensional densitometry. This 
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step is conveniently performed using the SAFA (Semi-Automated Footprinting 
Analysis) program.28 
22 Calculate absolute NMIA reactivity at each position in the RNA by subtracting (-) 
NMIA intensities from (+) NMIA intensities. (+) and (–) NMIA intensities should 
be normalized to each other by assuming the low intensity (unreactive) positions 
in each experiment have the same value. This calculation is equivalent to 
assuming that at least a few nucleotides will be unreactive in most RNAs. In 
assigning the SHAPE band positions, the cDNA markers generated by dideoxy 
sequencing are exactly 1 nucleotide longer than the corresponding (+) and (–) 
NMIA cDNAs.  
2.5.9 Troubleshooting guide for SHAPE. 
A variety of problems may be encountered in a SHAPE experiment (Table 2.1). 
Most problems may be diagnosed by inspection of the gel image. The nature of the 
problem is usually traceable to a unique step in the experiment or easily addressed 
problem.
 43 
Table 2.1 
Troubleshooting guide for a SHAPE experiment. 
Problem Reason Solution 
Bright bands present in the (–) 
NMIA lane. 
RNase contamination; this is, by 
far, the most common problem 
encountered for new practitioners 
of SHAPE technology. 
Identify contaminated solution by 
running mock SHAPE 
experiments with [32P]-labeled 
RNA. 
 Structure-induced pausing by the 
reverse transcriptase enzyme. 
Heat RNA in 0.5! TE to 95 °C 
for 3 min, cool on ice for 3 min 
before adding primer. 
Increase the time of extension to 
~30 min.  
Try primer extension reactions at 
different temperatures (±3 °C). 
Very low signal in the (+) NMIA 
lane but an intense full length 
product is observed. 
Insufficient modification of RNA. Perform modification using a 2-
fold higher concentration of 
NMIA. 
No full length product in the (+) 
NMIA lane or intense bands that 
disappear rapidly with read 
length. 
Excessive modification of RNA. Perform modification using a 2-
fold lower concentration of 
NMIA. 
No full length product in any 
lane.  
Poor or incomplete primer 
extension. 
The reverse transcriptase enzyme 
is very sensitive to MgCl2 
concentration. Make sure final 
solution conditions are 3 mM in 
MgCl2. Enzyme is also sensitive 
to freezing. Retry the experiment 
carefully with fresh enzyme.  
Smearing near the full length 
extension band. 
Incomplete degradation of the 
RNA strand or re-extension of the 
3'-end of the RNA in the RNA-
DNA hybrid. 
Decrease extension time; 
incubate at 95 °C with a higher 
concentration of NaOH. 
No sequencing bands in ddNTP 
sequencing lane(s). 
ddNTPs were incorporated in the 
wrong proportion. 
Adjust the ddNTP concentrations 
upwards or downwards by 2-fold. 
Extra bands in the ddNTP 
sequencing lane, not seen in (–) 
NMIA lane. 
Pauses in extension due to 
misfolding. 
Use a (–) NMIA reaction as the 
template for sequencing. 
No extension in (+) or (–) NMIA 
lanes, but extension in 
sequencing lanes. 
RNA lost during 
modification/precipitation. 
Perform the ethanol precipitation 
step in the presence of 20 µg 
glycogen as a co-precipitant. 
The faintest bands in the (+) 
NMIA lane have significantly 
different intensity as compared to 
the corresponding bands in the (-) 
NMIA lanes 
Random error involved with 
volume measurement; gel loaded 
unevenly. 
Small differences in background 
intensity can be treated by 
mathematical normalization (see 
step 22). If intensities are 
significantly different, the gel 
should be re-run by loading 
samples with similar amounts of 
cDNA fragments in each lane. 
 
 44 
          2.5.10 Anticipated results. 
A minimal SHAPE experiment consists 
of three or four lanes resolved in a 
sequencing gel (Figure 2.7). This 
representative experiment was 
performed using an in vitro transcript 
corresponding to yeast tRNAAsp 
embedded within the structure cassette 
shown in Figure 2.3. Two sequencing 
lanes were used to assign the SHAPE 
reactivities observed in the (–) and (+) 
NMIA reagent lanes. The bright bands 
at the top of the gel correspond to the 
relatively abundant full-length 
extension product. Bands corresponding 
to the unextended DNA primer and to 
short extension products, caused by 
pausing of reverse transcriptase during 
initiation of primer extension, are too 
short to be observed in this gel image. 
Approximately 90 RNA nucleotides are 
sufficiently well resolved that their 
absolute SHAPE reactivities can be 
 
Fig. 2.7. Representative SHAPE analysis 
for yeast tRNA
Asp
, embedded within a 
structure cassette. Typical results from a 
SHAPE experiment. G and A are sequencing 
reactions performed using cytosine and 
thymidine dideoxy terminating nucleotides. 
These marker lanes are exactly 1 nucleotide 
longer than the corresponding NMIA lanes. 
Nucleotide numbers (at left) correspond to the 
(–) and (+) reagent lanes. (–) and (+) NMIA 
lanes represent reactions differing only in the 
presence of the reagent. Regions expected to 
be unconstrained in the yeast tRNAAsp 
construct are emphasized with bars at the 
right of the gel image. 
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quantified. 
Positions in which SHAPE reactivity is significantly higher in the (+) NMIA 
reaction as compared to the no reagent (–) control are emphasized with vertical bars and 
correspond precisely to hairpin loops and unconstrained linker regions in the tRNAAsp 
construct (Figure 2.7). Band intensities can be quantified and absolute SHAPE 
reactivities at almost every position within the RNA are obtained by subtracting the (–) 
control intensities from the (+) NMIA intensities. Superposition of absolute band 
intensities on a secondary structure model for the tRNAAsp construct yields very precise 
information regarding the pattern of base pairing and the formation of non-canonical 
tertiary interactions in this RNA (bars, Figure 2.4B). Almost all base paired positions in 
tRNAAsp are unreactive; whereas nucleotides in the T-, D- and anticodon loops are 
reactive. For a more comprehensive discussion of SHAPE correlation with tRNAAsp 
structure, see Section 2.3.1 
 
2.6 Experimental Section 
2.6.1 Synthesis of tRNA
Asp
 Construct. A DNA template for transcription of 
tRNAAsp in the context of the structure cassette was generated by PCR [1.5 mL; 
containing 20 mM Tris (pH 8.4), 50 mM KCl, 2.5 mM MgCl2, 200 "M each dNTP, 500 
pM each forward and reverse primer, 5 pM template and 0.025 units/"L Taq polymerase; 
denaturation at 94 °C, 45 s; annealing 55 °C, 30 s; and elongation 72 °C, 90 s; 34 cycles]. 
Primer and tRNAAsp coding sequences are indicated in Figure 2.3. The PCR product was 
recovered by ethanol precipitation and resuspended in 300 µL HE [10 mM Hepes-NaOH 
(pH 8.0), 1 mM EDTA, the template was the coding sequence of tRNAAsp , and forward 
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and reverse primers contained the cassette sequences as well as ~18 nucleotides 
corresponding to the 5' and 3' ends of the coding sequence (Figure 2.3B)]. Transcription 
reactions (1.5 mL, 37 °C, 3 h) contained 40 mM Tris-HCl (pH 8.0), 10 mM MgCl2, 10 
mM DTT, 2 mM spermidine, 0.01% (v/v) Triton X-100, 4% (w/v) poly(ethylene) glycol 
8000, 2 mM each NTP, 75 µL PCR-generated template, and 0.1 mg/mL T7 RNA 
polymerase. The RNA product was purified by denaturing (8%) polyacrylamide gel 
electrophoresis, excised from the gel, and recovered by electroelution and ethanol 
precipitation. The purified RNA (~ 2.5 "mol) was resuspended in 100 "L HE.  
2.6.2 Structure-Sensitive RNA modification. RNA (20 pmol) in 6 "L sterile 
water was heated at 95 °C for 3 min, quickly cooled on ice, treated with 3 "L of folding 
buffer [333 mM NaCl, 333 mM Hepes-NaOH (pH 8.0), 33.3 mM MgCl2], and incubated 
at 37 °C for 20 min. The RNA solution was treated with NMIA (1 "L, 130 mM in 
anhydrous DMSO, 35 °C), allowed to react for 54 min (equal to 5 NMIA half-lives), and 
placed on ice. Control reactions contained 1 "L of DMSO in place of NMIA. In 
prequench reactions, the RNA was added after NMIA was allowed to degrade by 
hydrolysis. Modified RNAs were subjected to primer extension without further 
purification. 
2.6.3 Primer Extension. Modified RNA (2 µL, 4 pmol) was added to 5'-[32P]-
radiolabeled reverse transcription DNA primer (5'-[32P]-GAA CCG GAC CGA AGC 
CCG, ~ 0.2 pmol in 11 µL H2O), heated to 65 °C (6 min), and incubated at 35 °C (20 
min). Reverse transcription buffer [6 µL; 167 mM Tris-HCl (pH 8.3), 250 mM KCl, 10 
mM MgCl2, 1.67 mM each dNTP, 16.7 mM DTT] was added; the RNA was heated to 52 
°C; Superscript III (Invitrogen, 1 µL, 200 units) was added and mixed by gentle 
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pipetting; and reactions were incubated at 52 °C for 5 min. Primer extension reactions 
were quenched by addition of 1 µL of 4 M NaOH, heating (95 °C for 5 min), subsequent 
addition of neutralizing gel loading solution (29 µL; 40 mM Tris-borate, 276 mM Tris-
HCl, 5 mM EDTA, 0.01% (w/v) each xylene cyanol and bromophenol blue, 73% (v/v) 
formamide), and heating (95 °C, for an additional 5 min). Dideoxy sequencing markers 
were generated using unmodified RNA and adding 1 µL 10 mM dideoxy nucleotide 
triphosphate after addition of reverse transcription buffer. cDNA extension products were 
separated by denaturing electrophoresis [90 mM Tris-borate, 2 mM EDTA, 7 M urea, 8% 
(29:1) acrylamide:bisacrylamide); 100 W, 5 min; 72 W, 2.5 h; 0.75 mm ! 31 cm ! 38.5 
cm] and visualized by phosphorimaging. Two dimensional gel images were converted to 
plots of intensity versus position using ImageQuant. Individual band intensities for the 
(+) and (–) NMIA reactions were integrated using SAFA.28 
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CHAPTER 3 
 
NON-HIERARCHICAL INTERACTIONS DOMINATE EQUILIBRIUM STRUCTURAL 
TRANSITIONS IN tRNAAsp TRANSCRIPTS 
 
 
3.1 Introduction 
Essentially all RNA molecules have a propensity to form extensive interactions 
that locally constrain nucleotides in base-paired secondary structures and, often, in long-
range tertiary interactions.
1-3
 Nucleotides in folded RNAs thus differ significantly in the 
extent to which they are conformationally restrained by interactions with other parts of an 
RNA. Despite well documented exceptions,
4-6
 current models for RNA folding and for de 
novo prediction of RNA structure emphasize that RNA folding is strongly hierarchical. 
Hierarchical folding means that the base-paired secondary structure is both more stable 
than and forms independently of the tertiary structure. The hierarchical model has been 
difficult to test thoroughly because it has not been possible to evaluate experimentally 
folding states at nucleotide resolution for large RNAs. Nucleotide resolution is essential 
because functionally important helices often span only a few base pairs,
2
 and many 
important tertiary interactions in RNA involve only one or a few nucleotides.
7-9
 In the 
protein folding world, local residue dynamics are elegantly monitored in backbone amide 
hydrogen exchange experiments.
10,11
 A similarly comprehensive and nucleotide-
resolution experiment has not been developed for analysis of RNA structure and RNA 
folding intermediates. 
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The ribose 2'-hydroxyl group reacts with N-methylisatoic anhydride (NMIA) to 
form ester adducts at the 2' position.
12-14
 The reactivity of the 2'-hydroxyl group is gated 
by the underlying local structure such that flexible nucleotides react to form a 2'-O-
adduct more readily than nucleotides constrained by base pairing or tertiary 
interactions,
12
 as illustrated in Equation 3.1: 
 
O O
H
N
N
OO O
(RNA)constrained (RNA)flexible
OH
RNA
OH
kc
kf k2 [NMIA]
2' 2'2' CO2
 (3.1) 
2'-Hydroxyl reactivity scores local nucleotide flexibility because unconstrained 
nucleotides are better able to adopt an open conformation in which formation of a 2'-
oxyanion nucleophile is less destabilized by the adjacent 3'-phosphodiester anion.
12
 
Under our standard conditions, 2'-ester formation with NMIA (the pseudo-first-order 
k2[NMIA] step) occurs at a rate of 0.02 min
–1
 at highly reactive 2'-hydroxyl positions. 
This rate is many orders of magnitude slower than the rate constants for base pair 
opening,
10,15
 base flipping,
16
 or local base destacking
17
 processes, represented by the rate 
constants kf and kc in Equation 3.1. Studies with model compounds also indicate that 
flexible nucleotides react ~5–30-fold more slowly than nucleotide analogs specifically 
designed to reduce inhibition of the 2'-O-adduct forming reaction by the adjacent 3'-
phosphodiester.
12
 Thus, the equilibrium constant, represented by the ratio kf/kc, is less 
than 1, even for reactive, single-stranded positions. The rate constant for 2'-adduct 
formation, kadduct, is therefore determined by the fraction of time a nucleotide exists in the 
unconstrained, reactive conformation, multiplied by the rate of the chemical 
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transformation: 
 
 kadduct = Kf k2[NMIA] (3.2) 
 
 
where Kf = kf/kc and with the proviso that [NMIA] decreases during the reaction due to 
hydrolysis.12 A significant, perhaps counterintuitive, bonus of NMIA chemistry is that 
this reagent degrades by competitive hydrolysis with water
12
 which means that RNA 
structure can be monitored without the requirement that temperature-dependent reaction 
parameters be carefully controlled. 
 To use selective 2'-hydroxyl acylation to map RNA structure as a function of 
temperature, it is necessary to understand how the ability of 2'-O-adduct formation of 
nucleotides change with this variable. To measure ability of adduct formation as a 
function of temperature, the rates of hydrolysis and reaction with small nucleotide 
analogs were determined at different temperatures.
18
 The results from these experiments 
indicate that NMIA degrades on an experimentally tractable timescale (Figure 2.2C), and 
thus RNA structure probing can be performed without an explicit reagent quenching step. 
It is sufficient instead simply to allow RNA modification to proceed for five hydrolysis 
half lives. Furthermore, the activation enthalpy is a constant over a variety of 
temperatures and the fraction 2'-O-adduct formed at long times for each of the four 
nucleotide analogues is independent of temperature. This indicates that the absolute 2'-O-
adduct forming potential is a constant for an RNA nucleotide that does not undergo a 
change in conformation. If NMIA degradation proceeds to completion, no reactivity 
correction for temperature is required.  
Selective 2'-hydroxyl acylation thus represents an RNA analog of the widely 
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employed protein amide hydrogen exchange
10,11
 experiment in the bimolecular (EX2) 
limit. Because k2[NMIA] is slow, NMIA-based interrogation of RNA folding states is 
restricted to analysis of folding intermediates at equilibrium. Each nucleotide in an RNA 
cycles through all possible states, including unfolded states, weighted by the Boltzmann 
distribution. Flexible nucleotides will populate a different distribution of conformations 
than base paired or constrained positions. The conformation that most facilitates 2'-O-
adduct formation will dominate relative reactivity at any given position and flexible 
nucleotides will more often sample the most reactive conformations.12 Because all 
ribonucleotides have a 2'-hydroxyl, except for a few with post-transcriptional 
modifications at this position,
19,20
 structural information is, in principle, obtainable for 
every nucleotide in an RNA. 
In this chapter, I use RNA SHAPE mapping to analyze unfolding profiles for 
yeast tRNA
Asp
 transcripts with simultaneous interrogation of the local structural 
environment at almost every nucleotide. Even for this relatively simple and well studied 
RNA,
12,21-25
 SHAPE analysis reveals a pathway for unfolding intermediates that is 
significantly richer and more detailed than previously observable. The most thermally 
accessible states involve strong and non-hierarchical linkages between disparate elements 
of the tRNA structure. 
 
3.2 Results 
3.2.1 Nucleotide-resolution analysis of RNA folding intermediates. We used 
SHAPE to analyze thermally accessible states for yeast tRNA
Asp
 transcripts. Although 
this RNA does not contain the post-transcriptional modifications of the cellular RNA, 
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extensive prior work shows that the 
unmodified version folds into the 
correct L-shaped tRNA structure
23,24
 
and is bound and aminoacylated by 
its cognate synthetase 
indistinguishably from the wild type 
RNA.
26,27
 tRNA
Asp
 was synthesized 
in the context of an RNA structure 
cassette (Figure 3.1). This cassette 
embeds the tRNA within flanking 5' 
and 3' linker structures that facilitate 
detection of sites of 2'-O-adduct 
formation by primer extension.
12
 
SHAPE analysis shows that the internal tRNA
Asp
 structure folds autonomously and that 
the flanking hairpins fold independently, as designed.
12
 
The structure of the tRNA
Asp
 construct was analyzed by SHAPE at temperatures 
spanning 35 to 75 °C in intervals of ! 3.5 °C (Figure 3.2, left-most 18 lanes). The RNA 
was treated with NMIA at each temperature under single hit conditions
12
 and until 
reagent degradation was 97% complete (5 half-lives). Sites of 2'-O-adduct formation 
were mapped by primer extension. Strong stops to primer extension are not observed in 
control experiments omitting NMIA or in which NMIA was allowed to degrade prior to 
addition of RNA (compare –NMIA and pre-quench lanes with +NMIA reactions, Figure 
3.2). 
 
Fig 3.1. tRNA
Asp
 transcript in the context of an 
RNA structure cassette. tRNA
Asp
 structure is 
drawn to suggest orientation of helices and tertiary 
interactions in three-dimensional space. Tertiary 
interactions are indicated by dashed lines in gray. 
5' and 3' linker regions facilitate analysis of sites of 
2'-O-adduct formation by primer extension and 
have been shown to fold independently of the 
internal tRNA structure.
12
 By convention,
21,22
 
nucleotides in yeast tRNA
Asp
 are numbered 1-76, 
with residue 47 omitted. 
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Overall banding patterns for the 18 independent experiments show clear 
differences that reflect secondary and tertiary interactions and smooth transitions as a 
 
 
Fig. 3.2. Temperature dependent SHAPE analysis of tRNA
Asp
. RNA structural 
landmarks are indicated at left. For the (+) NMIA reactions, bands correspond to stops in 
reverse transcriptase-mediated primer extension and report sites of 2'-O-adduct formation; 
(–) NMIA lanes omitted reagent. Bands in the (-) NMIA lane represent small amounts of 
degredation as due to heating the tRNA in the presence of magnesium. The band 
intensities are significantly lower than their corresponding positions in the (+) NMIA lanes. 
The dideoxy sequencing ladder (A) is offset exactly 1 nucleotide longer than the 
corresponding 2'-adduct bands; nucleotide positions are numbered relative to NMIA lanes. 
For the prequench lane, NMIA was added and allowed to degrade prior to addition of RNA. 
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function of temperature (Figure 3.2, structural landmarks are indicated at left). The 
SHAPE experiment accurately reports the canonical structure of tRNA
Asp
 at 35 °C and 10 
mM MgCl2 because all highly reactive nucleotides lie in loops in tRNA
Asp
 or the 
structure cassette. With increasing temperature, the tRNA
Asp
 transcript more readily 
formed 2'-O-adducts, consistent with increased local nucleotide flexibility in the RNA 
(Figure 3.2). 
We quantified the folding state for almost every nucleotide in the RNA as a 
function of temperature. Band intensities were normalized to a unit scale to facilitate 
comparison between different nucleotides. We observed five distinct reactivity patterns 
(Figure 3.3). In the first group (Figure 3.3A), 10 positions including all residues in the T-
stem, as well as C2, C29, and C72, remained unreactive at all temperatures measured in 
this experiment (see 75 °C lane, Figure 3.2; summarized as filled stars in Figure 3.4). 
These residues correspond to positions that remain stably base paired below 75 °C.These 
nucleotides represent positions that have some of the strongest interactions in the entire 
RNA construct. 
In the second class (Figure 3.3B), ten nucleotides in tRNA
Asp
 (G18, U19, C20, 
U33, G34, U35, G37, C38, C75, and A76) exhibited roughly uniform high reactivity at 
all temperatures. These nucleotides are located in the anticodon loop, in the D-loop, and 
at the 3'-CCA terminus and correspond precisely to flexible, unpaired regions 
(summarized as red circles in Figure 3.4). 
For the third and fourth classes, many positions underwent well-behaved 
transitions in which 2'-hydroxyl reactivity changes smoothly between 35 and 75 °C. 
However, the tRNA
Asp
 construct does not unfold in a single transition or even in a few  
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Figure 3.3. Single nucleotide unfolding profiles for tRNA
Asp
. Profiles were computed by 
quantifying almost every band shown in Figure 3.2. (A-H) Profiles for each nucleotide binned by 
behavior. Data are plotted on a linear scale; dashed line indicates fraction melted = 0.5. 
Nucleotides with well-defined unfolding transitions (E-H) were fit to an equation assuming 
unimolecular denaturation and grouped according to Tm. Each group transition is indicated by a 
specific color (arrows, D-H) that will be used throughout this work. To determine which 
nucleotides are in each group transition, refer to Figure 3.4. 
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transitions. Instead, SHAPE quantitatively identified a minimum of six structural 
transitions for tRNA
Asp
 spanning ~50 to >70 °C (Figures 3.3A,D-H). Transition 
midpoints (melting temperatures, Tm) measured at each nucleotide are summarized in 
 Figure 3.4. We group the observed transition midpoints by color and this scheme is used 
consistently throughout this work. 
Structures in the third class show relatively simple behavior in which reactivity 
increased from a low to a high value (see, for example, D-stem residues 10-13 and 22-25 
in Figure 3.2) consistent with a monotonic 
transition from a structure constrained by base 
pairing or tertiary interactions to an 
unconstrained conformation (indicated by Tm in 
Figure 3.4). 
In contrast, in the fourth class, several 
nucleotides located in the D- and T-loops were 
reactive at 35 °C but additionally exhibited 
clear unfolding transitions with increasing 
temperature (see Figure 3.2; emphasized with a 
circled Tm in Figure 3.4). We infer that these 
are partially constrained positions that then 
experience greater conformational flexibility 
with increasing temperature. 
Finally, three positions were initially 
reactive but have structural profiles that showed 
 
Figure 3.4. Summary of structural 
transitions at nucleotide resolution 
superimposed on a secondary 
structure for tRNA
Asp
. Nucleotides 
are represented by their transition 
midpoint (Tm). Positions that have just 
begun to unfold at 70 °C or that unfold 
with a Tm >>70 °C are shown with 
open and closed stars, respectively. 
Colors correspond to melting 
temperature scheme used in previous 
and subsequent figures. Positions 
C28, U32, G39 and U54 (x) could not 
be analyzed, either because of 
electrophoretic band compression
25
 or 
absence of a reproducible profile. 
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complex two-phase transitions (for example, position G73 in Figure 3.2). At these 
nucleotides, 2'-hydroxyl reactivity first decreased and then increased (Figure 3.3C, 
diamonds in Figure 3.4). The net amplitude of the reduction in 2'-hydroxyl reactivity is 
comparable to that observed for the multiple, simple transitions in which reactivity 
increases. The observed, well defined, reduction and subsequent enhancement in 
reactivity is consistent with a model in which these nucleotides participate in new, 
constraining, interactions at intermediate temperatures which are then destabilized with 
increasing temperature. 
We were also able to monitor 2'-hydroxyl reactivity in significant portions of the 
5' and 3' regions of the structure cassette (Figures 3.1 and 3.2). All of the nucleotides in 
the 5' and 3' linker loops were reactive and all base-paired nucleotides in these structures 
showrd either no unfolding transition or an incomplete transition by 75 °C (comparable to 
the transitions shown in Figures 3.3A and 3.3D). Thus, helices in the structure cassette 
fold independently, as designed, and do not interfere with folding of the internal 
tRNA
Asp
. 
3.2.2 Comparison of SHAPE with absorbance-detected denaturation. We 
compared the nucleotide resolution information obtainable by the SHAPE approach 
(Figure 3.3) with a conventional absorbance-detected experiment, performed under 
identical solution conditions (Figure 3.5). RNA absorbance in the ultraviolet region 
increases with temperature due to disruption of base-stacking interactions (open symbols, 
Figure 3.5). Global unfolding features are more readily visualized in a first derivative plot 
(solid symbols, Figure 3.5), which shows two broad denaturation transitions for the 
tRNA
Asp
 transcript spanning ~ 45-75 and 75-90 °C. 
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The SHAPE experiments agree well with the absorbance melting profile 
(transitions detected by SHAPE are emphasized in color in Figure 3.5). The transitions 
detected at 51 and 58 °C correspond to features (just barely) detectable in the absorbance 
melting experiment. The transition maximum 
seen in the first derivative plot of the 
absorbance melting experiment (~ 63 °C) 
does not correspond to a single RNA 
unfolding transition but, instead, appears to 
report a convolution of the SHAPE-detected 
transitions occurring at 58 and 66 °C 
(compare blue and magenta regions with 
solid symbols in Figure 3.5). In sum, RNA 
SHAPE mapping is quantitatively consistent 
with the bulk RNA absorbance melting 
experiment but additionally yields structural 
information at nucleotide resolution. 
 
3.3 Discussion 
3.3.1 Model for the unfolding pathway of tRNA
Asp
 at single nucleotide 
resolution. The nucleotide-resolution SHAPE approach provides model-independent 
information on the local nucleotide environment in tRNA
Asp
 as a function of temperature 
(Figures 3.2, 3.3, and 3.4). In order to interpret these data and to develop structural 
models for tRNA
Asp
 folding intermediates, unfolding profiles for individual nucleotides 
 
Fig. 3.5. Absorbance melting profile of 
the tRNA
Asp
 transcript. Absorbance, 
monitored at 260 nm, and the first derivative 
with respect to temperature are shown with 
open and closed symbols, respectively. 
Nucleotide resolution transition ranges 
determined by SHAPE (Figure 3.3) are 
illustrated in color. RNA was incubated in 10 
mM MgCl2 and 100 mM NaCl. Temperature 
was increased at a rate of 1 ˚C per minute.  
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were placed into eight groups (Figures 3.3 and 3.4). There is relatively little subjectivity 
in these assignments. First, calculated Tm's have uncertainties that are ± 1 °C or less at 
most positions. Second, nucleotides binned into groups by Tm alone are located adjacent 
to each other in tRNA
Asp
, suggesting that the binning process reports authentic 
independently folding regions in the RNA (Figure 3.4). 
At 35 °C, SHAPE accurately reports the canonical structure
21,22
 of tRNA
Asp
 
(summarized in Figure 7A). Nucleotides in the T-, D- and anticodon loops and in the 3'-
CCA region were reactive; whereas, nucleotides involved in base pairing and tertiary 
interactions were unreactive. The anticodon stem is the least constrained of the four 
conserved paired regions and nucleotides in or adjacent to the G-U pair in this stem were 
also reactive (red nucleotides in Figure 3.6A). 
3.3.2 Two-phase loss of tertiary interactions for tRNA
Asp
. The first unfolding 
transition (Tm ~ 51 °C) involves disruption of the tertiary interactions that link the D- and 
T-loops (in orange, Figure 3.6B). In addition, nucleotides A9–U13, that span one strand 
of the D-stem, became flexible in this transition. U55–A57 and U59 in the T-loop and 
nucleotides A14–G17 in the D loop were moderately reactive at 35 °C and become more 
reactive over this temperature range. We infer that these positions are moderately flexible 
in the native ground state and are cooperatively disrupted in this transition. 
The second transition (Tm ~ 53 °C) involves complete unfolding of the D-stem, 
coupled with disruption of the tertiary interactions between the purine-rich strand 
(positions G22-U25) of this stem and nucleotides U8, A21, G45 and A46 (green positions 
in Figure 3.6C). In addition, nucleotides that comprise the stacked junction between the 
T- and acceptor stems (G6, A7 and C49) become flexible in this transition. Inspection of 
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the melting profiles makes clear that the 51 and 53 °C transitions are distinct (Figures 
3.3G,H). The 51 and 53 °C transitions are also detected independently in the absorbance 
melting experiment (Figure 3.5). 
An unanticipated result is thus that the purine- and pyrimidine-rich strands of the 
D-stem become conformationally flexible in an asymmetric way, average Tm's are 53 and 
51 °C, respectively. Only the pyrimidine-rich strand (nucleotides G10–U13) becomes 
unconstrained in the first transition and in concert with the T- and D-loops as judged by 
SHAPE chemistry (illustrated by removal of base pair symbols at orange nucleotides in 
Figure 3.6B). The purine strand melts with most of the tertiary interactions in this region 
at 53 °C (green symbols, Figure 3.6C). The asymmetric stability of the purine versus 
pyrimidine strands of the D-stem likely reflects two local structural differences. First, 
purine nucleotides may be better able to maintain inter-nucleotide stacking interactions in 
the absence of base pairing. Second, only the purine-rich side participates in significant 
tertiary interactions with other parts of the tRNA (dashed lines in Figure 3.6B). 
3.3.3 A conformational switch involving the anticodon and acceptor stems. In 
the next well isolated transition (Tm ~ 58 °C) both the anticodon and acceptor stems 
unfold asymmetrically. One strand of each helix unfolds " 7 °C higher than the other 
(compare Tm's in blue with other symbols in Figure 3.4). In addition, over this same 
temperature range, positions G30, C36 and G73 exhibit significant decreases in reactivity 
(Figure 3.3C, diamonds in Figure 3.4) and thus structural constraints increase at these 
well defined positions in the RNA (emphasized with blue downward arrowheads in 
Figure 3.6D). 
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Fig. 3.6. Nucleotide-resolution model for thermal denaturation of tRNA
Asp
. For each structure or 
intermediate (A-E), nucleotides that become newly reactive in a given transition are shown in color. 
Gray and black boxes (C,D) identify nucleotides proposed to participate in a conformational shift that 
maximizes G-C pairings. Up and down arrowheads emphasize positions that show two-phase 
behavior (see Figure 3.2C) and whose reactivity increases or decreases, respectively, in the 
indicated transition. Two additional transitions with Tm's ! 70 °C, involving disruption of the G27–
U32/G70–C75 helix and the T-stem helix, are not shown. 
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These two, distinct, observations are well explained if nucleotides on one side of 
each of the anticodon and acceptor stems (emphasized with gray and black boxes, Figure 
3.6C) undergo a conformational shift to form new G-C rich helices (gray and black 
boxes, Figure 3.6D). Thus, as one side of the acceptor and anticodon stems becomes 
locally flexible and reactive towards NMIA, the other side forms new constraining base 
pairs with complementary sequences in the RNA. This new structure (Figure 3.6D) is 
favored at higher temperatures because the absence of native tertiary interactions, that 
would otherwise enforce the canonical tRNA fold (see Figure 3.6A), changes the 
minimum energy structure. Alternatively, the conformational shift may reflect, in part, a 
temperature dependent change in #H for these secondary structure motifs. 
Nucleotides G37, C38, C74 and C75 likely also participate in the new helices. 
These nucleotides were partially reactive, at ~10-50% of the rate of the fully reactive A76 
position, over the entire temperature range (Figure 3.2). We interpret this conserved, 
intermediate reactivity to indicate that these nucleotides experience a series of stacking 
and base pairing constraining interactions throughout the temperature range. 
3.3.4 Ultimate stages of unfolding in three incremental steps. With increasing 
temperature, the helices formed as a result of the conformational shift (Figure 3.6D) then 
unfold incrementally and in an order consistent with calculated thermodynamic 
parameters.
28-30
 The short helix spanning G36–G39 and C67–G70 unfolds with a Tm of 
~66 °C (magenta positions in Figure 3.6E). The stem comprised of G27–U32 and G70–
C75 unfolds next because most of these nucleotides begin to react with NMIA by 75 °C 
(Figure 3.3D, illustrated with black up arrowheads in Figure 3.6E). Finally, the C:G rich 
T-stem unfolds with a Tm that must be significantly higher than 75 °C, consistent with the 
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observation that no detectable change in reactivity occurs at these positions through 75 
°C (Figure 3.3A; summarized with solid stars in Figure 3.4). 
 3.3.5 Implications for the RNA folding problem. The single-nucleotide 
resolution SHAPE analysis illustrates a complexity in folding states for tRNA
Asp
 
transcripts that is not anticipated by current models for RNA folding. First, RNA folding 
is thought to be strongly hierarchical such that the base-paired secondary structure is 
more stable than and forms independently of tertiary interactions.
1,3
 For the tRNA
Asp
 
construct, this model is clearly only partially predictive. It is true that the two lowest 
temperature transitions, at 51 and 53 °C, both involve loss of tertiary interactions. 
However, in both cases disruption of tertiary structure is coupled with the loss of simpler 
base-paired interactions (see Figures 3.6B and 3.6C). This coupling is so tight that the 
base paired D-stem is better viewed as an obligate component of the tRNA tertiary 
structure. 
Second, the structural stability of an individual helix is usually approximated to 
be uncoupled from the structure of other helices, with the exception of end-stacking 
effects.
30-32
 However, for tRNA
Asp
, there are two distinct examples in which the two 
strands in an RNA helix unfold asymmetrically due to structural coupling with other parts 
of the molecule. In the first example, the purine-rich strand of the D-stem becomes 
conformationally flexible at a higher temperature than the pyrimidine-rich strand of the 
same helix due to the influence of the tRNA tertiary structure (see Figures 3.6B and 
3.6C). Second, both the anticodon and acceptor stems melt asymmetrically, consistent 
with a conformational switch (Figures 3.6C and 3.6D) in which the partially denatured 
tRNA refolds to an alternate three-helix structure at elevated temperature. 
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 3.3.6 Facile analysis of RNA folding pathways. SHAPE chemistry makes 
possible quantitative analysis of RNA base pairing and tertiary interactions at single 
nucleotide resolution. Because NMIA reacts at the 2'-hydroxyl position, all nucleotides 
are interrogated and the absence of reactivity can be confidently assigned to persistent 
stability at a given local structure. The fundamental conclusion of this work is that, even 
for relatively simple tRNA
Asp
 transcripts, the equilibrium conformational states most 
structurally accessible from the native state are not well predicted by the hierarchical 
model for RNA folding. We are hopeful that the comprehensive and quantitative view of 
RNA structure afforded by the SHAPE approach will provide the experimental 
framework necessary for understanding the interrelationships between local and higher 
order folding in RNA. 
 
3.4 Experimental Section  
3.4.1 General. The tRNAAsp transcript was synthesized by in vitro transcription in 
the context of a structure cassette containing flanking 5' and 3' sequences (Figure 2) to 
facilitate analysis of the entire RNA by primer extension.12 The RNA was purified by 
denaturing electrophoresis and stored in 10 mM Hepes-NaOH (pH 8.0), 1 mM EDTA. 
All experiments were performed in 100 mM Hepes (pH 8.0), 100 mM NaCl, 10 mM 
MgCl2, 10% (v/v) dimethyl sulfoxide (DMSO), and 13 mM NMIA (Molecular Probes). 
3.4.2 Temperature-dependent RNA modification. RNA (6 $L, 20 pmol; in ~2 
mM Hepes, pH 7.5) was heated at 95 °C for 3 min, cooled on ice, treated with 3 $L of 
folding buffer [333 mM NaCl, 333 mM Hepes-NaOH (pH 8.0), 33.3 mM MgCl2], and 
incubated at 37 °C for 20 min. The RNA solution was then equilibrated for 5 min at the 
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reaction temperature (35-75 °C), treated with NMIA (1 $L, 130 mM in anhydrous 
DMSO), allowed to react for 5 hydrolysis half-lives (54 to 1.2 min for 35 to 75 °C, 
respectively), and placed on ice. No NMIA controls and prequench reactions were 
performed by substituting DMSO alone for NMIA or by allowing the NMIA to degrade 
prior to addition of RNA, respectively. Temperature gradient was established using an 
Eppendorf Gradient Thermocycler using 45 ± 10 and 65 ± 10 °C gradient settings; 
temperatures used were 34.9, 36.3, 38.0, 40.3, 42.9, 45.7, 48.4, 51.0, 53.2, 54.8, 58.3, 
60.6, 63.2, 65.9, 68.5, 71.0, 73.1, and 75.4 °C (see Figure 3.2). Efficiency of 2'-O-adduct 
formation was obtained from primer extension reactions, performed exactly as described 
in Chapter 2 and resolved on (8%) denaturing polyacrylamide gels. 
3.4.3 Quantification of RNA reactivity. The gel image was quantified by 
phosphorimaging and band intensities integrated using SAFA.33 Nucleotide reactivities 
were normalized to a uniformly reactive position (G18 for nucleotides G1–C49; A76 for 
G50–C75); absolute reactivities typically increased 5 to 8-fold for nucleotides that 
showed well defined melting transitions. Data obtained as a function of temperature at 
individual nucleotides were rescaled to a unit (0!1) scale and smoothed using a rolling 
weighting function.34 Transition midpoints (Tm) were obtained assuming a unimolecular 
transition:35  
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where I is the band intensity at a given temperature (T), R is the gas constant, and A and b 
are the transition amplitude and initial intensity, respectively. The van't Hoff enthalpy 
(!HvH) is returned by this equation but is characterized by large fitting errors. In contrast, 
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melting temperatures are generally (34 of 41 positions) reproducible to ± 1 °C or better. 
Error limits for nucleotides U11, U16, G65, C67, and G68 are ± 2 ˚C and for U40 and 
C43 are ± 3 °C. 
 3.4.4 Monitoring RNA denaturation by UV Absorbance. The tRNAAsp 
construct (5 µM, 600 µL, 100 mM NaCl, 10 mM MgCl2) was heated from 35 to 90 ˚C in 
an Applied Photophysics Pistar-180 spectrometer at 1 °C/min under exactly the 
conditions used in the SHAPE experiments (including DMSO, but omitting NMIA). 
After subtracting background from a sample omitting RNA, the denaturation profile, 
monitored at 260 nm, was smoothed34 and algebraically differentiated with respect to 
temperature. 
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CHAPTER 4 
 
HIGH THROUGHPUT SHAPE (hSHAPE) 
 
4.1 Introduction 
SHAPE chemistry is a useful tool to analyze the structure of any RNA. SHAPE 
interrogates nearly all nucleotides in an RNA, and can be performed under a wide variety 
of chemical and physical conditions to develop structural constraints. In a typical SHAPE 
experiment, RNA is sparsely modified in a structure-sensitive manner by an appropriate 
electrophile. The adducts, which form preferentially at flexible nucleotides, are detected 
by their ability to inhibit primer extension by reverse transcriptase. A control reaction 
omitting NMIA to assess background, as well as dideoxy sequencing extensions to assign 
nucleotide positions, are performed in parallel. The resulting cDNAs are quantified on a 
denaturing electrophoresis gel, where position and degree of modification correlates with 
length and amount of the extended primer.  
Denaturing slab-gel electrophoresis is a powerful tool for separating nucleic acids 
by length. However, the production and imaging of gels is a labor-intensive task, and 
band resolution can be poor near the origin of separation. Software that quantifies gel 
electrophoresis images, such as SAFA,1 typically cannot resolve and quantify more than 
200 bands per separation at single nucleotide resolution. However, there is nothing in the 
other steps of SHAPE that prevents analysis of reads that are several times as long.  
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A more appealing method to size and quantify extended cDNA primers is to 
employ a capillary electrophoresis instrument of the type commonly used for DNA 
sequencing. These automated instruments require less hands-on effort, and can separate, 
at single nucleotide resolution, fluorescently labeled DNA 100-700 nucleotides long. 
Additionally, raw elution data can be obtained in approximately 20% of the time it takes 
to produce an analagous gel image.  
The number of nucleotides interrogated in a single SHAPE experiment depends 
not only on the detection and resolution of separation technology used but also on the 
nature of RNA modification. Given reaction conditions, there is a length where nearly all 
RNA molecules have at least one modification. As primer extension reaches these 
lengths, the amount of extending cDNA decreases, which attenuates experimental signal. 
Adjusting conditions to decrease modification yield can increase readlength. However, 
lowering reagent yield also decreases the measured signal for each cDNA length. Given 
these considerations, the practical limit of a SHAPE experiment is probably around 1 
kilobase of RNA. 
In this chapter, I describe a high-throughput SHAPE experiment (hSHAPE). 
hSHAPE required the development of techniques and software to produce and quantify 
the cDNA products of a SHAPE experiment using a capillary electrophoresis system. To 
accomplish these goals, this work was completed with significant contributions from 
Morgan Giddings, Nicolas Guex, and Suzy Vasa.  
I use data from an analysis that encompasses the 5'-most ~300 nucleotides of an 
HIV-1 genome transcript to illustrate the principles of an hSHAPE experiment. This 
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region encompasses several structural 
domains, such as the TAR, primer 
binding site, and the ! site (described 
in Chapter 1). 
 
4.2 SHAPE and automated DNA 
sequencers 
 An hSHAPE experiment 
comprises four different reactions – a 
(+) NMIA, a (-) NMIA control and two 
dideoxy sequencing reactions (Figure 
4.1). Each of these extension reactions 
is performed using a 5'- fluorophore labeled DNA primer (Figure 4.1). The reaction and 
extension conditions are almost identical to a gel-based experiment, except that primer 
concentration is on the order of RNA concentration to ensure readable signal (For an 
overview of modification and extension steps, see Chapter 2). The fluorophores 
employed by hSHAPE are identical to the dyes normally used for DNA sequencing. The 
products of the extensions are combined and purified by recovery with ethanol 
precipitation and resolved in a single multi-fluor run by automated capillary 
electrophoresis.  
 
 
 
 
 
Fig. 4.1:  Steps of an hSHAPE 
experiment. Sequencing ladders and (+) 
and (-) NMIA extensions are performed 
using different fluorophores. Resulting 
cDNAs are separated on a DNA sequencer. 
Raw elution traces are analyzed by 
Basefinder.
2
 Correction for signal decay and 
normalization yield absolute SHAPE 
reactivity as a function of nucleotide 
position.  
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4.3 Analysis of hSHAPE data 
 4.3.1 Processing of raw elution traces. The resulting raw elution trace for the 5'-
end of the HIV-1 genome resembles a DNA sequencing experiment in that it reflects the 
products of specific primer extension termination events (Figure 4.2A). However, in an 
hSHAPE experiment, the absolute peak intensities as well as the elution times of peaks 
are meaningful in the (+) and (–) NMIA traces. For example, missing peaks or peaks with 
low reactivity in the (+) NMIA trace correspond to RNA nucleotides constrained by base 
pairing or other interactions. Intense peaks in the (+) NMIA trace identify unstructured or 
flexible nucleotides in the HIV-1 RNA. Elution times indicate the position of reactive and 
unreactive nucleotides. 
Each hSHAPE experiment contains a large peak at the low elution time that 
corresponds to unextended primers (Figure 4.2A). A large peak corresponding to full 
length RNA is observed at long elution times if the read extends to the 5'-end of an RNA. 
Between these two peaks, quantitative, single-nucleotide resolution RNA structure is 
obtained. 
We employ the signal processing framework of BaseFinder2 to analyze raw 
fluorescence versus elution time profiles. BaseFinder is a modular, extensible software 
package originally designed for DNA base calling and sequencing analysis. BaseFinder 
functions by applying a sequence of tools to a data trace. Each tool performs a specific 
analysis step, and contains adjustable parameters to account for experimental and 
stochastic variables, such as dye set and fluorescent baseline.  
The initial processing steps of raw sequencer traces are identical to those used for 
DNA sequencing. Fluorescent baseline is subtracted for each channel. Next, color  
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Fig. 4.2:  Signal processing of HIV-1 genome structural data using Basefinder
2
. Raw 
elution traces are analyzed to generate structural constraints for nearly every nucleotide in an 
RNA. (A) Raw fluorescent intensity versus time plot for HIV-1 genomic transcripts. Significant 
spectral overlap and baseline contributions are observed in the light red and light blue traces. 
(B) Correction for baseline, spectral overlap, and mobility yields traces corresponding to each 
of the reactions in a SHAPE experiment. (+) and (–) NMIA reactions (red and blue) are offset 
from the A and C sequencing lanes (black and green) for clarity. (C) Whole trace peak 
integration of (+) and (–) NMIA traces.  Peaks were fit to Gaussian curves (black dashed 
lines) and aligned to the sequencing channels.  Peaks in the sequencing channels are 
exactly 1 nucleotide longer than the (+) and (–) NMIA traces.  (D) Signal decay correction for 
the (+) NMIA trace assuming a constant probability for extension at each nucleotide (black 
line). 
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separation is performed to correct for spectral overlap of the multiple dyes such that each 
channel reports quantitative cDNA amounts (compare light blue line in Figure 4.2A to 
blue line in Figure 4.2B). The final analysis step common to DNA sequencing is the 
alignment of corresponding peaks in the four channels because each fluorophore imparts 
a slightly different electrophoretic mobility on cDNAs of the same length. The result of 
these analysis steps (Figure 4.2B) is an aligned plot of dye amount versus elution time for 
all the reactions in the SHAPE experiment. Each peak represents the amount of cDNA of 
a specific length. Corresponding peaks in all 4 traces are aligned so that they have the 
same elution time. 
Mobility shift and color separation parameters for a specific dye set may be 
generated on BaseFinder by careful analysis of separate RNA sequencing experiments. 
To develop color separation parameters for each dye, spectral overlap in each channel is 
determined in the absence of other fluorophores by analysis of a single nucleotide ladder. 
To develop mobility parameters, each of the different fluorophores is used to generate the 
same nucleotide ladder from the same RNA template. The ladders are separated in the 
same capillary column. Mobility shifts are determined by matching corresponding 
sequencing peaks throughout the read. Mobility and color separation parameters are 
specific to a dye set, and may be used on multiple RNA reads.  
 4.3.2 Quantification of sequencer data. Unique analysis steps are required for 
quantifying cDNA amounts in the (+) and (–) NMIA data traces to develop RNA 
structural constraints. Unlike DNA sequencing, where peak position is the most 
important factor, both the location and intensity of peaks in the NMIA data traces are 
important to locate and quantify nucleotide flexibility.  
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We have developed a new BaseFinder tool, called Align and Integrate3, that 
calculates peak area in the (+) and (–) NMIA traces versus nucleotide sequence. First, 
Align and Integrate detects and aligns peaks in the (+) and (–) NMIA traces with the 
RNA sequencing traces. Second, sequencing traces are compared and aligned with the 
sequence of the RNA being studied. Align and Integrate automatically accounts for the 
observation that cDNAs generated by sequencing are exactly 1 nucleotide longer than 
corresponding positions in the (+) and (–) NMIA traces.4,5 Finally, areas under each peak 
are determined by performing a whole trace Gaussian-fit integration. The overall result of 
applying BaseFinder to raw SHAPE traces is a set of (+) and (–) NMIA trace peak areas 
for every nucleotide position in the read (Figures 4.1 and 4.2C and D). 
Inspection of the resulting intensity data indicates signal decay associated with the 
(+) NMIA trace (Figure 4.2D). This signal likely reflects both the nature of NMIA 
reactivity as well as imperfect processivity of the reverse transcriptase enzyme. We 
corrected the drop by assuming that the probability of extension at each nucleotide was 
constant and slightly less than one: 
                                                       D = A p(elution time) + C                                            (4.1) 
 
Where D is the signal decay adjustment factor, A and C are scaling factors that reflect the 
arbitrary initial and final intensities of the trace, and p is the probability of extension at 
each nucleotide. Typical values for p span 0.995-0.999 for elution times in units of 2"s. 
We apply this equation to peak intensities representing average reactive nucleotides 
throughout the trace. The 2% of the most highly reactive peaks as well as peaks with 
reactivities near zero are excluded from the calculation. Each peak intensity calculated at 
the same elution time was divided by D. Signal decay correction results in an unbiased 
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data set that does not lose overall intensity as a function of readlength (compare Figures 
4.2D and 4.3A) Although uncommon, signal decay can also occur in the (–) if overall 
peak intensity is high in that trace. The steps to correct decay are the same as those for 
the (+) NMIA trace.  
 Because the (+) and (-) NMIA extensions are performed independently and use 
sequencing dyes with different quantum yields and spectral properties, the absolute scale 
for the (+) and (-) NMIA peak intensities are different. In order to quantitatively compare 
(+) and (-) NMIA peak intensities, we assumed that the peaks with the lowest ~10% of 
intensities throughout the (+) NMIA data accurately reflected the intensity of the 
corresponding (-) NMIA traces. We multiplied all peak intensities in the (-) NMIA trace 
by an appropriate factor that matched intensities to the unreactive nucleotides in the trace. 
The approach is insensitive to the dyes chosen for the (+) and (-) NMIA extensions. 
Indeed, interchanging the dyes used for the extensions produces nearly identical results.  
4.3.3 hSHAPE authentically measures local nucleotide flexibility. Several 
observations strongly support use of these processing steps and a very high level of 
precision for the hSHAPE experiment. Highly reactive nucleotides have similar SHAPE 
reactivities, independent of whether they lie at the 5' or 3' end of the RNA (red bars, 
Figure 4.3A). Absolute SHAPE reactivities, superimposed on the well-characterized6-8 
TAR and Poly(A) stem loops (nts 1-104) of the HIV-1 genome, show that SHAPE 
information is exactly consistent with the consensus secondary structure for this region 
(Figure 4.3B). Nucleotides in loops are reactive (red and orange bars, Figure 4.3B); 
whereas, base paired nucleotides are unreactive (purple bars, Figure 4.3B). Notably, 
SHAPE reactivities also accurately report fine-scale structural differences. For example,  
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Fig. 4.3:  Results of hSHAPE data processing on the HIV-1 genome transcript. (A) 
Processed SHAPE reactivities as a function of nucleotide position. Highly reactive 
nucleotides (red and orange bars) report flexible positions in the RNA. (B) Absolute NMIA 
reactivities superimposed on a secondary structure model for the TAR and Poly(A) stem-
loops. 
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nucleotides in the UCU bulge show intermediate reactivities, consistent with NMR 
studies9 that indicate that these nucleotides in the TAR stem are partially stacked.  
 
4.4 hSHAPE on long RNAs 
 A single hSHAPE experiment efficiently interrogates structural constraints for 
RNA ~300-600 nucleotides long. For longer RNAs it is necessary to combine multiple 
overlapping reads of the RNA from separate primer sets. To combine structural 
constraints in a single data set, all experiments are normalized to the same scale. Each 
SHAPE data set contains a few (~2%) exceptionally reactive positions, which do not 
represent generically flexible nucleotides. The normalization factor for each data set is 
determined by first excluding the most reactive 2% of peak intensities and the calculating 
the average for the next 8% of reactivities. All reactivities are then divided by this 
average. 
This simple normalization procedure generates SHAPE reactivities on a scale 
from 0 to ~2, where 1.0 is the reactivity of a flexible nucleotide (vertical axis, Figure 
4.3A). Nucleotides with reactivities greater than ~0.8 are almost always single stranded 
(red bars Figure 4.3A), while positions with reactivities less than ~0.2 (black and violet 
bars Figure 4.3A) are almost always paired. Nucleotides with normalized SHAPE 
reactivities between 0.2 and 0.8 may be paired or may participate in other partially 
constraining interactions. The standard deviation at each nucleotide averages 
approximately 0.1 SHAPE unit, as determined by repeat and overlapping reads on the 
HIV-1 genomic RNA.10  
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4.5 Development of an RNA structure from hSHAPE constraints 
SHAPE reactivities report direct and quantitative information regarding the extent 
of structure at each nucleotide in an RNA.  An important application of SHAPE 
technology is to develop well-supported structural models for a given RNA. The most 
successful structure prediction algorithms, such as RNAstructure, use a thermodynamic 
model based on nearest-neighbor free energy parameters11,12 to calculate the !G for 
potential structures for a given RNA sequence. The structure with the lowest calculated 
!G becomes the most highly predicted structure. However, the thermodynamic models 
used by these programs are approximate and RNA structure can be modulated by non-
thermodynamic constraints. Therefore, in silico methods often predict different structural 
topologies with nearly identical energies for a given sequence. Without additional 
structural information, it is not possible to choose which predicted structure reflects the 
native conformation of an RNA sequence. 
We modify the structure prediction program RNAstructure to include hSHAPE 
constraints in developing structural models.11,13 We calculate an energetic penalty or 
credit for pairing each nucleotide according to their SHAPE reactivity. This “quasi-
energetic” constraint provides a convenient and straightforward method for including 
SHAPE based constraints in structure prediction. Quasi-energetic constraints are an 
approximation of energetic penalties associated with pairing a nucleotide of a specific 
absolute SHAPE reactivity. 
To incorporate the quantitative nature of hSHAPE constraints into structure 
prediction, we calculate the “quasi-energy” by: 
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                                   !GSHAPE = m ln[ SHAPE reactivity + 1.0 ] + b (4.2) 
 
which is applied to each nucleotide in each stack of two base pairs. Therefore, the quasi-
energy is added twice per nucleotide paired in the interior of a helix and once per 
nucleotide paired at the end of a helix. The intercept, b, is the energy bonus for formation 
of a base pair with zero or low SHAPE reactivity while m, the slope, drives an increasing 
penalty for base pairing as the SHAPE reactivity increases. The b and m parameters 
shown to most likely produce a correct structure14 were –0.6 and 1.7 in units of kcal/mol, 
respectively (per nucleotide), but may be varied to modulate the energetic contribution of 
SHAPE reactivities in structure prediction. 
With hSHAPE information only, RNAstructure proposes helices only in regions 
that exhibit low reactivity. However, there is no constraint on the distance, in nucleotides, 
between the paired positions. Evidence from known RNA structures suggests that 
pairings between nucleotides 600 positions apart or more are nearly nonexistent, and 90% 
of basepairs occur between positions less than 300 nucleotides distant in sequence.15 
Therefore, constraining maximum sequence distance between pairing partners can 
improve the predictive power of RNAstructure. We have incorporated a tool that 
completely forbids pairings between positions greater than an arbitrary distance apart in 
sequence. To develop structural models, we find using a maximum allowed distance 
between base pairs of 600 provides sufficient constraints for many RNAs. Reducing this 
value to ~300 may be helpful in locating short, poorly predicted, and transient pairings 
that could be explained by more probable shorter distance interactions.  
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Despite the aid of hSHAPE and maximum pairing distance constraints, 
RNAstructure often predicts multiple different structures with nearly identical energies. 
Additionally, certain helices in a structure may be more well-determined than other 
paired regions in a secondary structure. To assess the robustness of a structural 
prediction, we vary the thermodynamic penalty of pairing associated with hSHAPE 
reactivities. Predicted base pairs were assigned a "pairing persistence" based on the range 
of parameters in which they are observed. Helices considered to be highly persistent were 
observed even when the parameters in Equation 4.2 were set to values as high as b = 0 
and m > 4. Increasing b and m has the effect of increasing the contribution of the SHAPE 
reactivity information on the secondary structure calculation. Helices with low pairing 
persistence are observed only at a lower SHAPE-imposed penalties.  
Varying the quasi-energetic contribution of SHAPE reactivity information in 
structure prediction is also useful in supporting a single secondary structure model when 
several are predicted at a single set of constraints. We assume that predicted helices that 
exist under the most stringent parameters most likely also exist under less stringent 
parameters. By following this assumption and by incrementally decreasing the stringency 
of parameters, a structural model with high pairing persistence can be "built" with the 
assistance of SHAPE parameters.10 
Using hSHAPE and maximum pairing distance to constrain RNA secondary 
structure prediction has a dramatic impact on the quality of predicted structures. For 
example, prediction accuracy improves from 52% to 90% for the 154 nt RNase P 
specificity domain16 and from 38% to 87% for the 1542 nt  Escherichia coli 16S rRNA.17 
SHAPE-directed predictions characteristically include overall topologies that closely 
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resemble the correct structure; errors tend to reflect small local structural rearrangements 
at the ends of helices and at multi-helix junctions. 
 
4.6 Perspective 
 hSHAPE technology represents a significant improvement to the SHAPE 
approach. No longer limited by gel electrophoresis, structural reads as long as 600 
nucleotides are accomplished in ~ 8 hours. The increased read length of hSHAPE 
technology decreases the amount of effort necessary to analyze long RNAs. The steps of 
an hSHAPE experiment may be completed in parallel, making it theoretically possible to 
complete dozens of analyses in a single day.  
Additionally, we have here developed a set of steps to propose accurate, well-
defined RNA secondary structures from raw sequencer data. Presently, several of these 
steps are incorporated into computer algorithms, but a significant amount of user input 
(~8h) is required to effect a single analysis. Continued work in developing software may 
make analysis of a SHAPE read possible in an hour or less. 
  Several RNA molecules of interest are thousands of nucleotides long, including 
some mRNAs, as well as viral genomes. hSHAPE makes analyzing the structure of and 
proposing structural models for these RNAs experimentally tractable. As an extreme 
example of RNA length, the SARS coronavirus RNA genome is 29,751 bases long. 
Assuming a readlength of 600 nucleotides and an overlap of 200 nucleotides at either end 
of the read, the entire SARS coronavirus may be interrogated, in duplicate, in less than 
200 reads.  
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4.7 Experimental Section 
4.7.1 HIV-1 RNA transcripts.  A DNA template encoding the 5' 976 nucleotides 
of the HIV-1 genome and containing a promoter for T7 RNA polymerase was generated 
by PCR [2 mL; 20 mM Tris-HCl (pH 8.4), 50 mM KCl, 2.5 mM MgCl2, 0.5 µM forward 
(5'-TAATA CGACT CACTA TAGGT CTCTC TGGTT AGACC) and reverse (5'-
CTATC CCATT CTGCA GCTTC C) primers, ~1 µg plasmid template containing a 
partial sequence of the HIV-1 pNL4-3 molecular clone (Genbank AF324493, obtained 
from the NIH AIDS Research and Reference Reagent Program), 200 µM each dNTP, and 
25 units Taq polymerase; 34 cycles]. The PCR product was recovered by ethanol 
precipitation and resuspended in 300 µL TE (10 mM Tris-HCl, pH 8, 1 mM EDTA).  
Transcription reactions [3 mL; 37 °C; 5 h; 40 mM Tris-HCl (pH 8.0), 5 mM MgCl2, 10 
mM DTT, 4 mM spermidine, 0.01% Triton X-100, 4% (w/v) PEG 8000, 300 µL PCR 
product, and 2 mM each NTP] were initiated by adding 0.1 mg/mL T7 RNA 
polymerase.18 The RNA product was precipitated and purified by denaturing 
polyacrylamide gel electrophoresis (5% acrylamide, 7 M urea), excised from the gel, and 
recovered by electroelution. The purified RNA (0.6 nmol) was resuspended in 100 µL 
TE. 
4.7.2 Modification of transcript RNA. RNA (2 pmol) in 14.4 µL of 1/2 " TE 
was refolded by heating at 95 °C, placing on ice, adding 3.6 µL folding buffer [250 mM 
Hepes-NaOH (pH 8), 1 M potassium acetate, pH 8, 25 mM MgCl2], and incubating at 37 
°C for 60 min. The folded RNA was divided equally between two tubes and treated with 
either NMIA5,19 (1 µL, 32 mM in DMSO) or neat DMSO (1 µL) and allowed to react for 
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60 min at 37 °C.  RNA from the (+) and (–) NMIA reagent experiments was recovered by 
ethanol precipitation and resuspended in 10 µL TE. 
4.7.3 Detection of 2'-O-Adducts by Primer Extension. RNA (1 pmol, 10 µL, in 
1" TE) corresponding to either the (+) or (–) NMIA reactions was heated to 95 °C for 3 
min and cooled on ice for 1 min. Fluorescently labeled primer (3 µL, complimentary to 
positions 342-363) was added to the (+) (0.2 µM Cy5) and (–) (0.4 µM WellRED D3) 
NMIA reactions, respectively, and primer-template solutions were incubated at 65 °C for 
5 min and 35 °C for 10 min. Primer extension was initiated by addition of enzyme mix [6 
µL; 250 mM KCl; 167 mM Tris-HCl (pH 8.3); 1.67 mM each dATP, dCTP, dITP, dTTP; 
10 mM MgCl2; 52 °C,1 min] and Superscript III (1 µL, 200 units, Invitrogen).  Extension 
continued at 52 °C for 15 min. Sequencing reactions used to identify peaks in the (+) and 
(–) reagents experiments were obtained using transcript RNA (1 pmol, in 9 µL TE), 3 µL 
primer (2 µM WellRED D2 or 1.2 µM LICOR IR 800), enzyme mix (6 µL), 1 µL of 
ddNTP solution (0.25 mM ddGTP or 10 mM other nucleotides), and Superscript III (1 
µL). Depending on the quality of synthesis, primers were purified by denaturing gel 
electrophoresis [20% polyacrylamide, 1" TBE, 7 M urea; dimensions 0.75cm " 28.5 cm 
(w) " 23 cm (h); 32W; 90 min] and passively eluted into 1/2" TE overnight.  The four 
reactions corresponding to a complete hSHAPE analysis [(+) NMIA, (–) NMIA, and two 
sequencing reactions] were combined, precipitated with ethanol in the presence of 
acetate, EDTA, and glycogen. Pellets were washed twice with 70% ethanol, dried under 
vacuum, and resuspended in deionized formamide. cDNA samples in 40 µL formamide 
were then separated on a 33 cm " 75 µm capillary using a Beckman CEQ 2000XL DNA 
sequencer. 
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CHAPTER 5 
 
STRUCTURES OF THE HIV-1 GENOME 
 
5.1 Introduction 
The HIV-1 RNA genome participates in multiple, pivotal, stages of the viral life 
cycle. It serves as mRNA for the synthesis of several viral proteins, is the substrate for a wide 
variety of splicing interactions, forms intermolecular dimer interactions that direct packaging 
and enable recombination between two RNA strands, base pairs with the tRNALys3 molecule 
that primes proviral DNA synthesis, acts as the template for viral DNA synthesis, and binds 
essential regulatory and cofactor proteins.1,2 The HIV genome represents a compelling target 
for antiviral therapies because it is simultaneously both the largest component of the virus 
and conserved interactions with proteins and other RNAs are critical for infectivity. 
However, our current understanding of HIV genomic RNA structure, and of the structures of 
virtually all long viral and cellular RNAs, has been largely limited to highly focused analyses 
of specific, short RNA domains and small genomic fragments. I employ, in collaboration 
with Robert Gorelick, Suzy Vasa, Nicolas Guex, Alan Rein, David Mathews, and Morgan 
Giddings, the methods described in Chapter 4 to analyze the structure of an intact HIV-1 
genome in infectious virions.  To characterize fully regulatory and protein-binding motifs, we 
also analyze the structure of genomic RNAs in which conserved RNA-protein interactions 
are disrupted in situ, and of purified viral RNAs free of other viral components.3 
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5.2 Results 
 5.2.1 Experimental approach. To analyze local nucleotide flexibility for long 
RNAs, such as the HIV-1 genome, we combined the results of multiple hSHAPE 
experiments performed on the same long RNA using primers that anneal 200-300 nts apart. 
Individual SHAPE reads were analyzed as described in Chapter 4. Combining normalized 
SHAPE reactivities from different reads is further supported in that overlapping regions are 
almost identical to each other (compare overlay of closed and open columns, Figure 5.1A).   
 
Fig. 5.1. hSHAPE is quantitative and highly reproducible. (A) SHAPE reactivities for two 
overlapping extension reactions using primers that anneal ~200 nucleotides apart. Solid and 
open bars indicate normalized SHAPE reactivities and standard deviations for primers that 
anneal at nts 342-362 and 535-555, respectively. (B) Complete SHAPE data for HIV-1 genomic 
RNA analyzed in virions and in the ex virio, AT-2 treated and monomer states. 
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5.2.2 Developing a structural model. Our goal is to develop structural models for 
the HIV-1 RNA genome as it exists inside infectious viral particles.  To detect virion-specific 
RNA conformational changes and RNA-protein interactions, we used hSHAPE to analyze 
the structures of four states in total.  In addition to (i) genomic RNA inside infectious virions 
(the in virio state), we analyzed (ii) authentic HIV-1 RNA gently deproteinized and extracted 
from virions (ex virio), (iii) genomic RNA in which select RNA-protein interactions were 
disrupted by treatment with Aldrithiol-2 (AT-2 treated, described in detail below), and (iv) a 
976-nucleotide HIV-1 monomer generated by in vitro transcription (termed the monomer 
state).  We obtained structural information for 94% of all nucleotides in these four states, in 
duplicate or better, for a total analysis of over 8,200 nts (Figure 5.1B). hSHAPE reactivities 
were then incorporated into structure prediction algorithms to propose secondary structures 
as described in Chapter 4.  
 We use the protein-free ex virio RNA as our reference state for the secondary 
structure of the 5' end of the HIV-1 genome (Figure 5.2). This structure strongly reflects the 
constraints imposed by SHAPE reactivities.  We could therefore assess the well-
determinedness of each helix in the secondary structure by varying the thermodynamic 
penalty imposed by the SHAPE constraints, which we term the pairing persistence. The most 
persistent helices (black and purple bars, Figure 5.2) were predicted even when SHAPE 
constraints were used to impose large pairing penalties for even slightly reactive nucleotides. 
Less persistent helices (blue and green bars, Figure 5.2) form only at a lower SHAPE-
imposed pairing persistence. 
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5.3 Discussion 
5.3.1 hSHAPE and previous mapping studies. hSHAPE structural constraints are 
consistent with previous qualitative structural mapping studies using chemical and enzyme 
reagents that analyzed a subset of the nucleotides analyzable by SHAPE. Given this 
similarity, elements of the SHAPE-constrained secondary structure (Figure 5.2) are similar to 
previously proposed models.4-6  For example, there is a strong consensus regarding the 
structures of several stem-loop motifs including the TAR, Poly(A), DIS, SD, and ! elements 
(labels, Figure 5.2). SHAPE analysis also supports formation of a previously proposed long-
range pseudoknot (nts 79-85/443-449).7  
Our secondary structure model also contains many, substantive, differences with 
respect to previous models.  Structural differences with respect to prior models reflect several 
contributions.  First, the hSHAPE data set is 94% complete.  Completeness is important 
because RNA secondary structure prediction using thermodynamic parameters alone 
typically yields structures with significant errors, especially as RNA length increases.8-10 In 
the case of HIV-1 genomic RNA, relatively little data had been obtained for positions 110-
125, 236-243, 276-282, 408-415, 432-435, and 465-477, which has led to structural 
proposals that are not consistent with the more complete hSHAPE data set. Second, end 
effects can dramatically alter structure prediction when only small pieces of a large RNA are 
analyzed.  Structures that involve or lie inside of long-range interactions, such as the 108-
114/335-341 stem must be mispredicted if the RNA sequence does not include the complete 
domain. Third, incorporation of SHAPE reactivity information as a pseudo-energy term 
makes the structure prediction calculation insensitive to errors in any single reactivity 
measurement.  Finally, we identify a structural domain that lies 3' of position 732 (Figure 
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5.2), which has not previously been analyzed. 
5.3.3 Structural differences in regulatory versus coding regions.  The 5' end of the 
HIV genome spans two functional regions whose boundary lies at the AUG start codon for 
the Gag coding sequence (nts 336-338; in bold, Figure 5.2).  Positions upstream of the AUG 
codon comprise a 343 nt long 5' regulatory domain; whereas, nucleotides 3' of the start codon 
span the Gag coding region, of which we have mapped >560 nts.  It is currently not possible 
to distinguish coding versus non-coding regions by secondary structure prediction alone.11,12  
By two criteria, SHAPE reactivities indicate that the 5' regulatory domain is more highly 
structured than the 3' mRNA-like region.  First, the average SHAPE reactivity, a metric for 
the extent of structure in the two regions, is 0.30 for the 5' regulatory domain and 0.44 for the 
3' mRNA-like region. (dashed lines, Figure 5.3).  Notably, the inflection point occurs almost 
exactly at the AUG start codon 
(gray bar, Figure 5.3) Second, in our 
secondary structure model (Figure 
5.2), nucleotides in the 5' regulatory 
domain are 1.7 times more likely to 
be paired than those in the 3' coding 
region.  Although the 3' coding region is relatively unstructured overall, several structured 
regions with high pairing persistence punctuate this region.  The most significant region 
spans positions 732-972.  Strikingly, this element occurs at exactly the boundary between the 
matrix and capsid domains of the Gag polypeptide.  We speculate that RNA structure at this 
site modulates translation of the Gag polyprotein to facilitate independent folding of the 
matrix and capsid domains.  hSHAPE may be broadly useful for identifying novel regulatory 
 
Fig. 5.3. Smoothed SHAPE reactivities (solid lines) 
and average reactivity (dashed lines) as a function of 
position 5' or 3' to the AUG Gag start codon. 
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motifs in cellular RNAs. 
5.3.4 Structures for distinct HIV genome states.  Comparison of the complete 
SHAPE reactivity profiles for the ex virio reference state with the other three states – in virio, 
AT-2 treated, and monomer – reveals that these distinct states contain extensive regions with 
identical structures.  This is a remarkable result considering, for example, that the in virio 
RNA was maintained in its native conformation inside virions throughout the chemical 
modification step; whereas, the monomer state was refolded after heating to 90 °C.  Thus, the 
functions of the HIV-1 genome appear to be governed by a single predominant conformation.   
In addition, analysis of the in virio state and comparison with the protein-free ex virio 
RNA reveal numerous regions that are persistently accessible to SHAPE chemistry.  These 
regions are expected to hybridize readily with complementary sequences, including antisense 
and RNAi-based oligomers, and represent multiple new and attractive targets for anti-HIV 
therapeutics (red and orange positions, Figure 5.2). 
Reactivity profiles for these four states also show important structural differences, 
which can largely be interpreted in terms of local RNA conformation and protein-binding 
effects. There are three regions with significant differences between the ex virio reference 
state and the monomer RNA, which was refolded in vitro.  The most dramatic difference is 
that the monomer RNA is much more reactive at positions 182 to 199 (see difference plot, 
Figure 5.4A).  This region maps exactly to the tRNALys3 primer binding site2 and indicates 
that the primer remains paired to the HIV-1 RNA genome in viral particles. The ex virio state 
also has higher SHAPE reactivity at positions 161-166 and lower reactivity at positions 168-
170, as compared with the monomer state.  These reactivity changes are consistent with 
tRNALys3-induced structural rearrangement at nucleotides 141-170 due to multi-site 
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interactions between the tRNA and genomic RNA (Figure 5.2, gray nucleotides), a subset of 
which have been identified previously.13 The monomer state, which is not bound by tRNA, 
folds into a different local structure in these regions (compare Figures 5.2 and 5.4B). 
 
In all normal retroviral particles, the genomic RNA is in a dimeric form, with similar 
or identical RNA strands linked together by a limited number of base pairs and tertiary 
interactions.  The dimeric structure is a critical element in the selective encapsidation of the 
genome14,15 and template-switching between two RNA monomers during reverse 
transcription leads to recombination,16,17 a major source of genetic variation for retroviruses. 
Dimerization is generally thought to involve an initial loop-loop interaction18 at the self-
complementary sequence G257CGCGC262.  These nucleotides are unreactive in both the 
monomer and ex virio states (boxed nucleotides, Figure 5.2), which supports formation of 
constraining base pairing interactions at this loop.  Thus, even the monomer state forms a 
loop-loop dimer.  A similar 'early' loop-loop dimer state has been identified for the Moloney 
 
Fig. 5.4. RNA conformational changes that differentiate ex virio and transcript monomer 
states. (A) SHAPE reactivity as a function of nucleotide position for ex virio (red) and transcript 
(black) RNAs.  Difference plot in lower panel has been smoothed over a five nucleotide 
window.  (B) Secondary structure model for the primer binding site in the absence of tRNA
Lys3
. 
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murine sarcoma retrovirus.19,20 We observed no reactivity differences greater than 0.1 SHAPE 
units between the monomer and ex virio RNAs in sequences flanking the 257-262 loop 
(compare red and black traces in Figure 5.1B and 5.4A).  This result was surprising because 
current models postulate18 that the stem sequences adjacent to this loop form a stable 
intermolecular duplex involving both genomic RNA strands. Similar SHAPE reactivities in 
this region do not support formation of an intermolecular duplex in mature HIV-1 viral 
particles, although we cannot exclude a change yielding identical local nucleotide flexibilities 
in the pre- and post-dimer RNAs. 
 5.3.5 Direct analysis of NCp7-RNA genome interactions.  NMIA is a small, mildly 
hydrophobic reagent, which we found readily crosses the retroviral membrane. We analyzed 
the structure of HIV-1 genomic RNA inside infectious virions by treating viral particles with 
NMIA and then extracting and processing the modified RNA (the in virio state; Figure 5.5B).  
We observe numerous reproducible differences between the ex virio and in virio states 
(Figures 5.1B,5.5B) that must report virion-specific RNA structures and RNA-protein 
interactions. 
The most prominent protein ligand for genomic RNA in mature HIV virions is the 
nucleocapsid protein.21,22  The nucleocapsid protein (NCp7) contains two highly conserved 
“zinc-knuckle” motifs comprised of cysteine and histidine residues that coordinate zinc ions 
and bind preferentially to guanosine (Figure 5.5A). These compact motifs are flanked by 
positively charged residues that interact at adjacent RNA elements.23,24  “Zinc ejecting” 
agents like 2,2'-dithioldipyridine (or Aldrithiol-2, AT-2; Figure 5.5C) quantitatively disrupt 
interactions between the zinc ion and its cysteine ligands, and thus compromise NCp7-RNA 
interactions, but leave the surface of the virus particle intact.25 We therefore disrupted 
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nucleocapsid-RNA interactions in situ by treating virions with AT-2 and then analyzed the 
structure of the resulting genomic RNA using hSHAPE (Figures 5.5 and 5.6). 
 
 
 
 
Fig. 5.5. Effects of disrupting HIV-1 nucleocapsid-RNA interactions.  (A) Amino acid 
sequence and an RNA-bound conformation
23
 of the HIV-1 NCp7 protein.  Schemes for 
analyzing HIV-1 genomic RNA structure in virio (B) and following zinc-ejection with AT-2 (C).  
(D) SHAPE reactivities as a function of nucleotide position for ex virio, in virio, and AT-2 states.  
Difference plot (lower panel) illustrates effect of AT-2 treatment on SHAPE reactivity relative to 
in virio genomic RNA.  Reactivity differences are smoothed over a five nucleotide window.  
Sites of enhanced SHAPE reactivity upon AT-2 treatment are indicated with arrowheads. 
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The effect of AT-2 treatment is highly specific because large regions of the genomic 
RNA in the intact in virio and AT-2 treated states show identical SHAPE reactivities.  In 
contrast, disrupting NCp7-RNA interactions by “zinc-ejection” both increases and decreases 
local nucleotide flexibility in other distinct genome regions (Figures 5.5D and 5.6).  
Strikingly, the strongest and most systematic effects of AT-2 treatment lie in the 5' regulatory 
domain and are largely absent after position 580 in the 3' coding region (upward and 
downward pointing arrowheads, respectively; Figure 5.2). 
Regions showing a strong increase in SHAPE reactivity in the AT-2 treated state 
almost always resemble the protein-free ex virio state (compare blue and red traces, Figures 
5.5D and 5.6).  We infer that a strong increase in reactivity in the AT-2 treated samples at 
these sites reflects disruption of specific NCp7-RNA interactions.  The single strongest NCp7 
binding site lies at positions 272-274, followed closely by positions 241-244 (upwards 
pointing arrowheads in Figures 5.2 and 5.5D).  These sites, which have not been previously 
implicated in NCp7 or Gag recognition, are consistent with primary interaction motifs for the 
viral nucleocapsid domain at the 5' end of the HIV-1 genome. 
 5.3.6 Definition of a nucleocapsid interaction domain.  Inspection of the strongest 
NCp7 binding sites (upward facing arrowheads, positions 241-244, 272-274, 288-292, and 
308-312, Figure 5.2), plus several secondary sites (positions 224-227, 318-320 and 326-329) 
indicate that the consensus NCp7 RNA recognition motif spans 1-2 guanosine residues in a 
single-stranded region of ~4 nts adjacent to a helix.  Most such sites lie in a single domain in 
our model for the HIV-1 genome (positions 224-334, Figure 5.2).  This domain overlaps 
structures that play a major role in HIV-1 genomic RNA packaging21 and also includes the 
G257CGCGC262 that likely forms intermolecular base pairs in the genomic RNA dimer (Figure 
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5.2). We propose that the 223-334 domain dimer interacts, potentially cooperatively, with 
multiple copies of the HIV-1 NCp7 protein and with the nucleocapsid motif in the Gag 
protein.  The specific juxtaposition of high affinity NCp7/Gag binding sites in the dimer 
would then function as the structural motif that is specifically packaged in nascent HIV 
virions. 
  
5.3.7 Structure destabilizing activity of the nucleocapsid domain.  Whereas the 
nucleocapsid domain binds specifically to retroviral RNA in its packaging function, the 
protein also has an almost opposing function, that of binding non-specifically to nucleic acids 
and facilitating structural rearrangements.22  hSHAPE analysis detects this alternate activity 
directly.  The presence of intact NCp7, prior to AT-2 treatment, increases SHAPE reactivity 
and, by inference, flexibility in two regions of the genomic RNA (downward facing arrows, 
 
 
 
 
Fig. 5.6. NCp7 increases SHAPE reactivity and, by inference, RNA flexibility in regions 5' 
to the primer binding site. Absolute SHAPE reactivities are shown for the ex virio (red), in 
virio (green) and AT-2 treated (blue) states.  Difference plot reports the effect of AT-2 treatment 
on the in virio state; points have been smoothed over a 5 nt window. 
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Figures 5.2 and 5.6).  Local nucleotide flexibility is enhanced at 5 sites 5' of the tRNA primer 
binding site, which likely functions to facilitate initial extension of the tRNA primer during 
the earliest stages of retroviral cDNA synthesis.  Flexibility is also increased at ~9 sites 3' of 
the Gag start codon and might function to enhance either cDNA synthesis or translation by 
reducing RNA structure in this region. 
 
5.4 Perspective   
Using a concise set of experiments, we have obtained single nucleotide resolution 
structural information for 94% of the first 900 nucleotides of the HIV-1 genomic RNA inside 
infectious virions.  Because SHAPE reactivities are quantitative and highly reproducible, we 
could interpret structural differences between intact genomic RNA in authentic particles with 
three other instructive states, representing a total analysis of over 8,200 nucleotides. These  
comparisons support multiple new and revised models for the intimate role of RNA genome 
structure in retroviral replication and infectivity. High-throughput RNA structure analysis 
will make possible analysis of the complete and intact RNAs that constitute a viral or cellular 
transcriptome, as a function of multiple biological states. We anticipate that hSHAPE will 
facilitate analysis of the underlying contributions of RNA structure to translational 
regulation, alternative splicing, higher-order packaging in compact viruses, and many other 
RNA-based processes. 
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5.5 Experimental Section 
 5.5.1 HIV-1 particle production. VSV-G pseudotyped HIV-1 NL4-3 viral particles 
were produced by cotransfecting the pNL4-3 (Genbank AF324493) and pHCMV-G (VSV-G 
protein expression construct)26 plasmids at a ratio of 3:1 into 293T cells as described27 except 
that TransIT293 (Mirus Bio) was used to increase transfection efficiency. In sum, 40 " 150 
cm2 culture flasks, seeded at a density of 3 " 106 293T cells were transfected.  Cultures were 
incubated for 48 hours and supernatants harvested, clarified by centrifugation at 5000 g for 
10 min, filtered through a 0.2 µm membrane, and stored at 4 °C overnight.  Cultures were 
incubated for an additional 24 hours with fresh culture media, and virus-containing 
supernatant was again collected using the same procedure.  Supernatants from both harvests 
were pooled at 4 °C in preparation for treatment with the AT-2 and NMIA reagents.  Viral 
particle genomes were quantified by real-time RT-PCR;26 the yield is typically 40 pmol HIV-
1 RNA genomes/L cell culture. 
5.5.2 HIV-1 particle treatment with AT-2.  Aldrithiol-2 (AT-2, systematic name 
2,2'-dithiodipyridine; 0.5 M in DMSO, 2.0 mL) or DMSO (2.0 mL) was added to 1.0 L virus 
supernatant and incubated overnight at 4 °C. Virus particles from the (+) and (–) AT-2 
experiments were pelleted separately by centrifugation (113,000 gmax, 4 °C, 1.5 h) through a 
20% (w/v) sucrose cushion in phosphate buffered saline.  Pellets were resuspended in 1.0 mL 
NMIA reaction buffer [50 mM Hepes-NaOH (pH 8), 200 mM NaCl, 0.1 mM EDTA, and 
10% fetal bovine serum].  
5.5.3 NMIA modification of viral particles.  Concentrated samples of either purified 
viral particles or particles treated with AT-2 (500 µL) in NMIA reaction buffer were treated 
with NMIA (50 µL, 100 mM) or neat DMSO (50 µL) for 50 min at 37 °C.  The virus particle 
 105 
production, AT-2 treatment, and NMIA modification steps were always performed as a 
single continuous process and without intermediate storage steps. 
5.5.4 Extraction of HIV-1 Genomes from NMIA-modified Particles.  RNA 
genomes subjected to reaction with NMIA in virio were gently extracted from viral particles 
as described.15 In sum, concentrated samples of virus particles (in 550 µL NMIA buffer) were 
incubated at ~22 °C with 5 µL Proteinase K (20 mg/mL), 33.5 µL 1 M Tris-HCl (pH 7.5), 
13.4 µL 5 M NaCl, 1.34 µL 0.5 M EDTA, 6.7 µL 1 M DTT, and 4 µL glycogen (20 mg/mL) 
for 30 min. RNA was purified by three consecutive extractions with phenol-chloroform, 
followed by precipitation with ethanol. Samples were resuspended in 1/2" TE to a 
concentration of 0.5 µM, based on quantitative RT-PCR analysis. 
5.5.5 Extraction and SHAPE analysis of HIV-1 Genomes from native particles.  
For the ex virio state, pelleted viral particles were dissolved in 1 mL of 50 mM Hepes-NaOH 
(pH 8.0), 0.5 mM EDTA, 200 mM NaCl, 1% (w/v) SDS, and 100 µg/mL proteinase K and 
digested for 30 min at ~22 °C. The RNA was then extracted against phenol-chloroform and 
the resulting deproteinized genomes were then aliquoted (2 pmol) and flash frozen at –80 °C.  
For SHAPE analysis, the ex virio RNA was treated with NMIA using the same procedure as 
for modification of the monomer state (described above), except that the initial 90 °C heat 
step was omitted, and the time for incubation in folding buffer was reduced to 10 min. 
5.5.6 Detection of 2'-O-Adducts by Primer Extension.  In vitro transcript (prepared 
and modified as described in Chapter 4) or authentic genomic RNA corresponding to either 
the (+) or (–) NMIA reactions served as a template for primer extensions as described in 
Chapter 4. Sequencing experiments were also performed as described. Four sets of primers 
were used that were complementary to positions 342-363, 535-555, 743-762, or 956-976.  
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5.5.7 Data Processing.  Data processing was performed as described in Chapter 4. In 
sum, raw fluorescence intensity versus elution time profiles were analyzed using the signal 
processing framework in BaseFinder28 to (i) correct baseline, (ii) correct color separation for 
spectral overlap of the fluorescent dyes such that each channel reported quantitative cDNA 
amounts, and (iii) correct mobility to align corresponding peaks in the four channels.  Areas 
under each peak in the (+) and (–) NMIA traces were obtained by (i) peak detection and 
interpolation to align peaks in each channel with the RNA sequence and (ii) performing a 
whole trace Gaussian-fit integration.29  Signal decay correction and normalization were 
completed manually as described (Chapter 4). 
5.5.8 Incorporation of hSHAPE constraints into RNAstructure.  hSHAPE 
constraints were incorporated into RNAstructure-based prediction as a quasi-energetic 
constraing (Chapter 4). For the HIV-1 RNA, the b and m parameters were –0.6 and 1.7 
kcal/mol, respectively (per nucleotide) and the maximum allowed distance between base 
pairs was restrained to be 300 nts or less.  Pairing persistence of individual helices was 
determined and used to build the structural model (Chapter 4). 
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